# v2.6.0 Development Prompts

## Prompt 1: Single-Patient Journey Orchestration

The main prompt below is to be run autonomously by you, providing updates with each of the 12 separate commits (GitHub is updated throughout the project under a single PR) - with no user intervention. Don’t ask questions or go into plan mode throughout this prompt. It is important that all files utilized and created for each stage are not overwritten. You are responsible for comprehensive understanding and application of all aspects of the repository for the new outputs. This includes, where relevant: all code, all code types, machine learning and AI types, different robot types and characteristics, digital twins, examples, patients, physical ai unification, unification standard level (USL), tools, etc. Use the full 1M token Opus 4.6 context length throughout the outputs.

For any documentation: avoid large white empty spaces without text. Avoid large spacing between words. Make sure text, code, and file names don’t run off the right side of the page anywhere. Avoid lines with a single word. Avoid single lines separate form the paragraph on the next page. Perform the final formatting steps that a senior author would take by correcting white space formatting, removing and/or adding relevant text to make each section and page look properly formatted and self standing by itself. (Don’t overcrowd the page with text, some white space formatting is ok). Make sure to correct all incorrect symbols such as SS into “§” where relevant. Only use em dashes for the regulatory titles. No logos are allowed anywhere throughout the work.

“USE WHERE RELEVANT”
“Physical AI Oncology Trial Single-Patient Journey” 
“Draft release” 
“Released on 20 March 2026” 
“10.5281/zenodo.19119939” with hyperlink https://doi.org/10.5281/zenodo.19119939 
“CEO Kevin Kawchak”
“ChemicalQDevice”
“The original CFR documents are in the public domain. The original ICH document is copyrighted and may be used, reproduced, incorporated into other works, adapted, modified, translated or distributed under a public license. This current work is not endorsed or sponsored by CFR, ICH, or FDA; and was adapted using Claude Code Opus 4.6.”
“USE WHERE RELEVANT”

Update physical-ai-oncology-trials main readme documentation, repository structures, text diagrams and toc, a link and explanation to this new GitHub pages based on the blue doi badge and doi url, and other affected areas in the repository (this is the only repository that needs to be edited). Make sure the repository is fully up to date with this work regarding badges, content, and context.

Provide a copy of this v2.6.0 prompt under patient-journey/prompts.md. Be sure to fix and address errors that would cause failed checks for the single pull request (such as for lint and Python environment issues to avoid the following error during final checks): "3 failing checks
x Cl / lint-and-format (3.10) (pull...
x Cl / lint-and-format (3.11) (pull...
x Cl / lint-and-format (3.12) (pull... " Place the new release notes in releases.md under main using the format below. Update other relevant documentation such as project structures. Update the main Readme diagrams, repository structure, etc. where necessary. Adapt the main prompt’s CHANGELOG.md (below) into the existing repository CHANGELOG.md format (v2.6.0).

"FORMAT"
Release title
v2.6.0 - [Fill in Title Here]

## Summary

## Features

## Contributors
@kevinkawchak
@claude
@openai
@google-gemini

## Notes



“START MAIN PROMPT”
You are a clinical software engineer working in the physical-ai-oncology-trials repository (v2.5.0, 51 Python modules, 1,289+ tests). Your task is to build the complete single-patient journey — tracing Patient PAT-2026-0042 (58F, Stage IIIB NSCLC, ECOG 1, PD-L1 65%, TMB 14 mut/Mb, SITE-003) — through every phase of a physical AI oncology trial, from referral through closeout.
You will execute 12 sequential commits, each building on the prior without overwriting any previously committed files. Each commit creates new files in a patient-journey/ top-level directory and corresponding tests in tests/test_patient_journey/. After all 12 commits, the repository will contain a complete, runnable, fully tested patient journey orchestration layer with comprehensive visualizations, FDA cost-savings analysis, and pharmaceutical industry deliverables.
Push every commit to the branch you are developing on using git push -u origin <branch-name>. Provide a brief status update after each commit confirming what was created and pushed.

STAGE PROGRESS DIAGRAMS — REQUIRED FOR EVERY STAGE COMMIT (Commits 1–10)
Each of the 10 stage commits (Commits 1–10) must include 3 text-based progress diagrams that visualize the patient's cumulative progress through that stage and all prior completed stages. These diagrams are saved as plain-text .txt files in a dedicated subdirectory for each stage.
Directory Structure for Diagrams
patient-journey/
├── diagrams/
│   ├── stage_01/
│   │   ├── perspective_a_timeline.txt
│   │   ├── perspective_b_regulatory.txt
│   │   └── perspective_c_clinical.txt
│   ├── stage_02/
│   │   ├── perspective_a_timeline.txt
│   │   ├── perspective_b_regulatory.txt
│   │   └── perspective_c_clinical.txt
│   ├── ...  (stage_03 through stage_10, same 3 files each)
│   └── stage_10/
│       ├── perspective_a_timeline.txt
│       ├── perspective_b_regulatory.txt
│       └── perspective_c_clinical.txt
Three Perspective Types (SAME for all 10 stages, cumulative)
Perspective A — Timeline & Milestone Tracker (perspective_a_timeline.txt) A horizontal or vertical ASCII timeline diagram showing:
* All stages from Stage 1 through the current stage, with dates/day ranges
* Completed stages marked with [DONE], current stage marked with [ACTIVE], future stages marked with [PENDING]
* Key milestones at each completed stage (e.g., "PHI cleared", "Consent obtained", "Twin calibrated", "Robot USL 7.9", "Surgery complete", etc.)
* Cumulative day count and elapsed time
* Example for Stage 3:
PAT-2026-0042 JOURNEY TIMELINE — Through Stage 3: Digital Twin Construction
═══════════════════════════════════════════════════════════════════════════════

Day -30          Day -14           Day 0            Day 7           Day 14    ...
  │                │                 │                │                │
  ▼                ▼                 ▼                ▼                │
┌──────────┐  ┌──────────┐   ┌──────────────┐       │                │
│ STAGE 1  │  │ STAGE 2  │   │   STAGE 3    │       │                │
│ [DONE]   │→ │ [DONE]   │ → │  [ACTIVE]    │       │                │
│Pre-Screen│  │Enrollment│   │ Digital Twin  │       │                │
└──────────┘  └──────────┘   └──────────────┘       │                │
  PHI cleared    Consented     Twin calibrated   [PENDING]        [PENDING]
  FHIR mapped    Arm A assigned  4 growth models  Robot Qual       Surgery
  DICOM valid    IRB approved    V&V 40 passed    ...              ...

Cumulative: 37 days elapsed | 3 of 10 stages complete | Status: ENROLLED
Perspective B — Regulatory Compliance Tracker (perspective_b_regulatory.txt) An ASCII table/matrix diagram showing:
* Rows: Each regulatory framework (21 CFR Part 312, 21 CFR Part 50, ICH E6(R3))
* Columns: All 10 stages
* Cells: Specific section numbers addressed at each stage, marked [✓] for completed stages, [→] for current stage, [ ] for pending
* Running count of total regulatory sections satisfied cumulatively
* Example for Stage 3:
PAT-2026-0042 REGULATORY COMPLIANCE — Through Stage 3
══════════════════════════════════════════════════════════════════════════

Framework          │ S1-PreScr │ S2-Enroll │ S3-DTwin │ S4-Robot │ S5-Surg │ ...
───────────────────┼───────────┼───────────┼──────────┼─────────┼─────────┤
21 CFR Part 312    │[✓] §312.1 │[✓] §312.20│[→]§312.21│[ ]      │[ ]      │
                   │    §312.3 │    §312.23│   §312.23│         │         │
                   │    §312.57│           │   §312.402         │         │
───────────────────┼───────────┼───────────┼──────────┼─────────┼─────────┤
21 CFR Part 50     │[✓] §50.1  │[✓] §50.20 │[→] §50.32│[ ]      │[ ]      │
                   │    §50.3  │    §50.25 │          │         │         │
                   │    §50.33 │    §50.27 │          │         │         │
                   │           │    §50.30 │          │         │         │
                   │           │    §50.31 │          │         │         │
                   │           │    §50.34 │          │         │         │
───────────────────┼───────────┼───────────┼──────────┼─────────┼─────────┤
ICH E6(R3)         │[✓] §2.9   │[✓] §2.4   │[→] §1.4  │[ ]      │[ ]      │
                   │           │    §2.7   │    §1.4.1│         │         │
                   │           │    §2.8   │    §1.4.2│         │         │

Cumulative: 22 of 84+ regulatory sections addressed | 3 frameworks active
Perspective C — Clinical & Technical Status Dashboard (perspective_c_clinical.txt) An ASCII dashboard showing the patient's cumulative clinical and technical state:
* Patient demographics and diagnosis (static)
* Current clinical status (stage, status, treatment arm, day)
* Physical AI systems status (robots qualified?, digital twin status?, USL scores?)
* Adverse events to date (count, max grade)
* Data integrity metrics (audit entries, MCP conformance level, data lock status)
* Module activation count (how many of 51 repo modules activated so far)
* Example for Stage 3:
PAT-2026-0042 CLINICAL & TECHNICAL DASHBOARD — Through Stage 3
══════════════════════════════════════════════════════════════════════════

┌─ PATIENT ──────────────────────┐  ┌─ TRIAL STATUS ──────────────────┐
│ ID:    PAT-2026-0042           │  │ Stage:    DIGITAL_TWIN (3/10)   │
│ Age:   58F                     │  │ Status:   ENROLLED              │
│ Dx:    Stage IIIB NSCLC        │  │ Arm:      A (Experimental)      │
│ ECOG:  1                       │  │ Day:      7                     │
│ PD-L1: 65%  TMB: 14 mut/Mb    │  │ Site:     SITE-003              │
└────────────────────────────────┘  └─────────────────────────────────┘

┌─ PHYSICAL AI SYSTEMS ──────────────────────────────────────────────────┐
│ Digital Twin:  CALIBRATED (4 growth models, V&V 40 validated)          │
│ Da Vinci Xi:   [PENDING QUALIFICATION]                                 │
│ Franka Panda:  [PENDING QUALIFICATION]                                 │
│ Realtime Sync: Configured (30 Hz intraop, event-driven otherwise)      │
└────────────────────────────────────────────────────────────────────────┘

┌─ SAFETY & COMPLIANCE ─────────┐  ┌─ DATA METRICS ──────────────────┐
│ Adverse Events:  0            │  │ Audit Entries:     ~45          │
│ Max AE Grade:    N/A          │  │ MCP Conformance:   CLINICAL_READ│
│ Device AEs:      0            │  │ Data Lock:         OPEN         │
│ Consent:         OBTAINED v1  │  │ Modules Active:    15 of 51     │
│ IRB:             APPROVED     │  │ Regulatory Sects:  22 addressed │
└───────────────────────────────┘  └─────────────────────────────────┘
Key rules for diagrams:
1. Each stage's diagrams are cumulative — they show all prior stages' data plus the current stage
2. The same 3 perspective types are used for every stage (Timeline, Regulatory, Clinical/Technical)
3. Diagrams grow richer with each stage as more data accumulates
4. Stage 10 diagrams should be the most comprehensive, showing the complete journey
5. Diagrams are plain .txt files (no code, no imports) — purely text-based ASCII art
6. Each diagram file should be 40–80 lines

REGULATORY FRAMEWORK
Three LaTeX regulatory adaptations in the repository define the Physical AI legal requirements that govern every stage of this patient's journey:
1. Physical AI Adaptation of 21 CFR Part 312 (regulatory/Adaption-21-CFR-Part-312/source/Physical_AI_21_CFR_Part_312.tex) — 64 sections across Subparts A–I, plus new Subpart J (§ 312.400–312.405) for Physical AI System Classification, Validation, Cybersecurity, Human Oversight, and Lifecycle Management.
2. Physical AI Adaptation of 21 CFR Part 50 (regulatory/Adaption-21-CFR-Part-50/source/Physical_AI_21_CFR_Part_50.tex) — 20 sections across Subparts A–D, plus new Subpart C (§ 50.30–50.34) for Physical AI Safety Requirements, IRB Review, Ongoing Consent, Data Protection, and System Classification.
3. Physical AI Adaptation of ICH E6(R3) (regulatory/adaption-ich-e6r3/source/main.tex) — Sections 1.1–1.5 (Principles, System Classification, AI/ML Framework Requirements, Simulation/Digital Twin Requirements, USL Framework) and Sections 2.1–2.12 (Investigator Responsibilities including Physical AI oversight) and Section 3.1 (Sponsor Quality Management).
Each stage orchestrator must include inline comments citing the specific regulatory section(s) that govern that stage's operations. These citations appear in the detailed specifications below.

REPOSITORY CONVENTIONS (MUST FOLLOW)
All new Python files must follow these exact conventions observed across the existing 51 modules:
Convention	Detail
Header	#!/usr/bin/env python3
Docstring	Triple-quoted, with title, description, Usage section, "Last updated: March 2026"
Disclaimer	"RESEARCH USE ONLY - Not for clinical decision-making." in module docstring
License	"LICENSE: MIT" in module docstring
Imports	from __future__ import annotations, then stdlib → third-party → local
Logging	logger = logging.getLogger(__name__)
Data classes	@dataclass with typed fields, field(default_factory=...) for mutables
Enums	class XxxStatus(Enum) for all state machines
Conditional	try: import X except ImportError: X_AVAILABLE = False; warnings.warn(...)
Line length	120 characters max (ruff.toml: line-length = 120)
Target	Python 3.10+ (ruff.toml: target-version = "py310")
Lint rules	E, F, W selected; F841, E741, E501 ignored
RNG seed	np.random.seed(42) in test fixtures (mirror tests/conftest.py)
Test loading	Use importlib.util.spec_from_file_location() for hyphenated directory imports (mirror tests/conftest.py load_module pattern)
Critical: Each commit creates NEW files only. Files from prior commits are NEVER overwritten. Some files (like patient_state.py and master_journey.py) are created once and are designed from the start to accommodate all 10 stages. Do NOT go back and edit files from prior commits — design them to be complete or additive from the outset.

COMMIT 1 — STAGE 1: PRE-SCREENING & REFERRAL INTAKE (Day −30 to Day −14)
Clinical context: Patient PAT-2026-0042 is referred from a community oncologist. Raw clinical records, imaging, and demographics arrive at the trial site. All data must be scanned for PHI, de-identified, harmonized to standard vocabularies, and validated before any trial processes begin.
Governing regulations:
* Physical AI Adaptation of § 312.1 (Scope — extends IND requirements to Physical AI components)
* Physical AI Adaptation of § 312.3 (Definitions — Physical AI system terminology)
* Physical AI Adaptation of § 50.1 (Scope — extends human subject protections to Physical AI interactions)
* Physical AI Definitions in § 50.3 (consent-relevant definitions for robotic systems)
* § 50.33 (Data Protection for Physical AI Investigations — HIPAA, de-identification, MCP-PAI servers)
* ICH E6(R3) § 2.9 (Records and Reports — adequate, accurate, audit-trailed)
Files to create:
File 1: patient-journey/__init__.py
* Single-line docstring: """Patient journey orchestration for Physical AI Oncology Trials."""
File 2: patient-journey/patient_state.py (THE CENTRAL DATA MODEL — designed once to span all 10 stages)
* This file must be complete from the start — it defines every data structure used across all 10 stages
* Enums:
    * PatientStage — 10 values: PRESCREENING, ENROLLMENT, DIGITAL_TWIN_CONSTRUCTION, ROBOT_QUALIFICATION, SURGERY, RECOVERY, IMMUNOTHERAPY, FEDERATION, SURVEILLANCE, CLOSEOUT
    * PatientStatus — REFERRED, SCREENING, ELIGIBLE, CONSENTED, ENROLLED, RANDOMIZED, ACTIVE_TREATMENT, SURGERY_SCHEDULED, SURGERY_COMPLETE, RECOVERING, ON_IMMUNOTHERAPY, SURVEILLANCE, COMPLETED, WITHDRAWN
    * TreatmentArm — EXPERIMENTAL, CONTROL, PLACEBO
    * ResponseCategory — CR, PR, SD, PD (RECIST 1.1)
    * AESeverity — MILD, MODERATE, SEVERE, LIFE_THREATENING, FATAL (CTCAE v5.0)
    * ConsentStatus — PENDING, OBTAINED, AMENDED, WITHDRAWN
    * DataLockStatus — OPEN, SOFT_LOCK, HARD_LOCK
    * PhysicalAIClassification — SURGICAL_ROBOT, COBOT, HUMANOID, THERAPEUTIC, DIAGNOSTIC, ASSISTIVE, REHABILITATIVE (per ICH E6(R3) § 1.2 and § 312.401)
    * USLReadinessLevel — FOUNDATIONAL (1.0–4.9), INTERMEDIATE (5.0–6.9), ADVANCED (7.0–8.9), CLINICAL_GRADE (9.0–10.0) (per ICH E6(R3) § 1.5)
    * MCPConformanceLevel — CORE, CLINICAL_READ, IMAGING, FEDERATED_SITE, ROBOT_PROCEDURE (per § 50.33 five cumulative levels)
* Core dataclasses:
    * PatientDemographics — patient_id, age, sex, ethnicity, smoking_status
    * TumorProfile — tumor_type, stage, grade, volume_cm3, molecular_markers (dict), growth_rate, histology
    * Biomarkers — pdl1_tps, tmb, egfr, alk, ros1, msi, kras, braf, her2, ntrk
    * OrganFunction — ecog, renal_function (eGFR), hepatic_function (Child-Pugh), cardiac_ef, pulmonary_fev1
    * AdverseEvent — event_id, description, severity (AESeverity), organ_system, onset_day, resolution_day, resolved (bool), causality, related_to_device (bool), reported_to_irb (bool), reported_to_fda (bool), ctcae_grade (int)
    * TreatmentCycle — cycle_number, start_day, drug, dose_mg, dose_modifications, labs_pre (dict), labs_post (dict), toxicities (list[AdverseEvent]), response_assessment (optional ResponseCategory)
    * SurgicalRecord — procedure_date_day, procedure_type, robot_id, robot_classification (PhysicalAIClassification), operative_time_min, estimated_blood_loss_ml, margins_status, lymph_nodes_sampled, lymph_nodes_positive, complications, specimens (list[str]), pathology_stage, usl_score_at_procedure (float), autonomy_level (int)
    * ImagingTimepoint — day, modality, tumor_volume_cm3, response_category, notes
    * DigitalTwinState — twin_id, model_type, current_volume_cm3, proliferation_rate, calibrated (bool), last_updated_day, predictions (dict), validation_score (float)
    * RobotQualification — robot_id, robot_type, robot_classification (PhysicalAIClassification), usl_score (float), usl_readiness (USLReadinessLevel), safety_validated (bool), calibration_error_mm (float), deployment_ready (bool), iec_80601_compliant (bool), cybersecurity_validated (bool)
    * FederationContribution — round_number, day, model_type, epsilon_spent (float), gradient_norm (float)
    * RegulatoryEvent — event_type, day, description, document_id, cfr_section (str), status
    * ConsentRecord — consent_status (ConsentStatus), version, date_day, physical_ai_appendix_included (bool), robot_types_disclosed (list[str]), autonomy_levels_disclosed (bool), override_rights_disclosed (bool)
    * AuditEntry — timestamp_day, action, actor, details, electronic_signature (str), cfr_part_11_compliant (bool)
    * PatientJourneyState — THE MASTER STATE OBJECT containing:
        * demographics (PatientDemographics)
        * tumor (TumorProfile)
        * biomarkers (Biomarkers)
        * organ_function (OrganFunction)
        * stage (PatientStage)
        * status (PatientStatus)
        * consent (ConsentRecord)
        * treatment_arm (optional TreatmentArm)
        * enrollment_day (optional int)
        * surgical_record (optional SurgicalRecord)
        * digital_twin (optional DigitalTwinState)
        * robot_qualifications (list[RobotQualification])
        * treatment_cycles (list[TreatmentCycle])
        * imaging_timepoints (list[ImagingTimepoint])
        * adverse_events (list[AdverseEvent])
        * federation_contributions (list[FederationContribution])
        * regulatory_events (list[RegulatoryEvent])
        * audit_trail (list[AuditEntry])
        * data_lock (DataLockStatus)
        * mcp_conformance_level (MCPConformanceLevel)
        * outcome (optional dict with pfs_days, os_days, response_type, max_toxicity_grade)
    * Helper methods on PatientJourneyState:
        * advance_stage(new_stage) — validates legal transitions, logs audit entry
        * add_adverse_event(event) — appends and auto-checks reporting thresholds (per Physical AI Adaptation of § 312.32)
        * add_regulatory_event(event) — appends with CFR section citation
        * add_audit_entry(action, actor, details) — creates timestamped 21 CFR Part 11 compliant entry
        * get_current_day() — returns most recent day from any timeline event
        * summary() → dict — returns compact summary of current state
File 3: patient-journey/stage_01_prescreening.py (~300-400 lines) This module orchestrates Day −30 to Day −14 for a single patient. It must define a class PreScreeningOrchestrator with methods that reference (import and call) the existing repository modules:
1. __init__(self, patient_data: dict, site_id: str) — accepts raw referral data
2. scan_for_phi(self, documents: list[str]) -> dict — calls privacy/phi-pii-management/phi_detector.py → PHIDetector to scan all incoming referral documents for 18 HIPAA Safe Harbor identifiers (per § 50.33 Data Protection requirements and 45 CFR 164.514(b)(2)). Returns detection results per document with PHICategory classifications, confidence scores, and locations. Blocks processing if unredacted PHI found in unprotected channels.
3. deidentify_records(self, records: list[dict]) -> list[dict] — calls privacy/de-identification/deidentification_pipeline.py → DeidentificationPipeline.deidentify_record() and apply_safe_harbor(). Strips all 18 identifier categories per § 50.33 HIPAA Safe Harbor requirements. Assigns de-identified ID PAT-2026-0042. Applies date-shifting (random offset ±180 days, consistent per patient). Returns de-identified records.
4. harmonize_clinical_data(self, raw_data: dict) -> dict — calls federation/data_harmonization.py → DataHarmonizationEngine, DICOMNormalizer.normalize() (standardizes CT to 512×512, 1mm slice, Lung kernel), FHIRResourceMapper (converts to FHIR R4 Patient/Condition/Observation per ICH E6(R3) § 1.4.2 Digital Twin Systems data requirements), VocabularyHarmonizer.map_icd10_to_snomed() (maps C34.1 → SNOMED 254637007). Returns HarmonizationResult with mapping confidence scores.
5. validate_dicom(self, dicom_series: list[dict]) -> dict — calls tools/dicom-inspector/dicom_inspector.py to validate DICOM attributes (PatientID, StudyDate, Modality, SliceThickness, PixelSpacing), RT-STRUCT/RT-DOSE/RT-PLAN compliance. Flags non-compliant series.
6. create_patient_record(self, harmonized_data: dict) -> PatientJourneyState — calls digital-twins/clinical-integration/clinical_dt_interface.py → FHIRClient.test_connection(), ClinicalConnector.get_patient(), creates initial PatientRecord. Builds and returns PatientJourneyStatewith demographics, tumor profile, biomarkers, organ function populated. Sets stage to PRESCREENING, status to REFERRED. Sets mcp_conformance_level to CLINICAL_READ (per § 50.33 MCP-PAI conformance).
7. provision_access(self, patient_id: str, site_id: str) -> dict — calls privacy/access-control/access_control_manager.py to create initial audit trail entry PATIENT_REFERRAL_RECEIVED, provision temporary read-only access for screening team (per Physical AI Adaptation of § 312.57 Recordkeeping and ICH E6(R3) § 2.9.3 audit trail requirements), generate 21 CFR Part 11 compliant electronic signature on data receipt.
8. run(self) -> PatientJourneyState — orchestrates all above methods in sequence, returns fully initialized patient state. Logs each step to audit trail. Records RegulatoryEvent for scope applicability under Physical AI Adaptation of § 312.1.
Each method must include:
* Detailed docstring explaining clinical context
* Logging at INFO level for each major operation
* Error handling that logs at ERROR level and records to audit trail
* Inline comments citing the governing Physical AI regulatory section(s) from the .tex files (e.g., # Per Physical AI Adaptation of § 312.3 — Physical AI Definitions)
File 4: patient-journey/diagrams/stage_01/perspective_a_timeline.txt
* ASCII timeline showing Stage 1 as [ACTIVE], Stages 2–10 as [PENDING]
* Key milestones: PHI scanned, records de-identified, FHIR mapped, DICOM validated, patient record created
* Day range: Day −30 to Day −14
* Cumulative: 1 of 10 stages active | Status: REFERRED
File 5: patient-journey/diagrams/stage_01/perspective_b_regulatory.txt
* Regulatory compliance matrix showing Stage 1 sections addressed: § 312.1, § 312.3, § 312.57, § 50.1, § 50.3, § 50.33, § 2.9
* All other stages blank/pending
* Cumulative: 7 regulatory sections addressed
File 6: patient-journey/diagrams/stage_01/perspective_c_clinical.txt
* Clinical dashboard showing initial patient data populated
* Physical AI systems: all pending
* Adverse events: 0 | Consent: PENDING | Data lock: OPEN
* Modules active: 6 of 51
File 7: tests/test_patient_journey/__init__.py
* Empty or single-line docstring
File 8: tests/test_patient_journey/test_stage_01_prescreening.py (~200-250 lines)
* Use importlib.util.spec_from_file_location() to load patient_state.py and stage_01_prescreening.py(following the load_module() pattern from tests/conftest.py)
* @pytest.fixture(autouse=True) that seeds np.random.seed(42)
* Fixtures: sample_referral_data() (synthetic patient demographics matching PAT-2026-0042), sample_documents() (list of strings containing synthetic PHI), sample_dicom_metadata() (dict with required DICOM attributes)
* Tests (at least 15):
    * test_patient_state_creation — verifies PatientJourneyState initializes with correct defaults
    * test_patient_stage_enum_values — all 10 stages present
    * test_physical_ai_classification_enum — all 7 robot types from ICH E6(R3) § 1.2
    * test_usl_readiness_level_enum — FOUNDATIONAL/INTERMEDIATE/ADVANCED/CLINICAL_GRADE
    * test_mcp_conformance_level_enum — all 5 levels per § 50.33
    * test_phi_detection_finds_identifiers — synthetic PHI detected
    * test_deidentification_removes_phi — output records contain no PHI
    * test_data_harmonization_maps_codes — ICD-10 → SNOMED mapping correct
    * test_dicom_validation_passes_valid — valid DICOM metadata passes
    * test_dicom_validation_fails_invalid — missing attributes flagged
    * test_patient_record_creation — PatientJourneyState populated correctly
    * test_access_provisioning — audit entry created with Part 11 compliance
    * test_prescreening_run_end_to_end — full run() method produces valid state
    * test_advance_stage_valid_transition — PRESCREENING → ENROLLMENT allowed
    * test_advance_stage_invalid_transition — PRESCREENING → SURGERY raises error
Commit message:
Add Stage 1: Pre-screening & referral intake (Day -30 to -14)

Create patient-journey/ directory with core PatientJourneyState data model
spanning all 10 stages (incl. Physical AI classification per § 312.401,
USL readiness per ICH E6(R3) § 1.5, MCP conformance per § 50.33), and
Stage 1 orchestrator for PHI detection, de-identification, data
harmonization, DICOM validation, and FHIR integration. 3 progress
diagrams (timeline, regulatory, clinical). 15 tests.

COMMIT 2 — STAGE 2: ELIGIBILITY SCREENING & ENROLLMENT (Day −14 to Day 0)
Clinical context: Patient evaluated against inclusion/exclusion criteria, informed consent obtained with physical AI appendices, stratified randomization assigns treatment arm, regulatory agents verify compliance.
Governing regulations:
* Physical AI Adaptation of § 312.20 (Requirement for an IND — Physical AI components in IND scope)
* Physical AI Adaptation of § 312.23 (IND Content and Format — robot capability profiles, USL scores, simulation data)
* Physical AI Adaptation of § 50.20 (General Requirements for Informed Consent — extends to Physical AI interactions)
* Physical AI Adaptation of § 50.25 (Elements of Informed Consent — 8 basic elements + Physical AI Additional Elements including robot types, AI algorithms, data collection, safety measures, right to non-Physical AI alternative, Physical AI-specific risks)
* Physical AI Adaptation of § 50.27 (Documentation of Informed Consent — Physical AI System Summary section)
* § 50.30 (Physical AI System Safety Requirements — pre-procedure safety matrix)
* § 50.31 (IRB Review of Physical AI Investigations)
* § 50.34 (Physical AI System Classification and Regulatory Pathways)
* ICH E6(R3) § 2.8 (Informed Consent for Physical AI Interactions — 6 specific elements: (a) system description, (b) AI algorithm role, (c) data collection, (d) safety measures, (e) right to non-Physical AI alternative, (f) Physical AI-specific risks)
* ICH E6(R3) § 2.7 (Randomisation and Blinding in Physical AI Trials)
* ICH E6(R3) § 2.4 (Communication with IRB/IEC)
Files to create:
File 1: patient-journey/stage_02_enrollment.py (~350-400 lines) Class EnrollmentOrchestrator with methods:
1. __init__(self, patient_state: PatientJourneyState, trial_config: dict) — accepts patient state from Stage 1 and trial protocol configuration
2. check_eligibility(self, criteria: dict) -> dict — calls federation/site_enrollment.py → SiteEnrollmentManager.check_eligibility(). Evaluates inclusion criteria (confirmed NSCLC, Stage IIIB, ECOG 0-1, PD-L1 ≥ 50%, adequate organ function — ALL MET). Evaluates exclusion criteria (prior immunotherapy, autoimmune disease, active brain mets — NONE TRIGGERED). Returns eligibility result dict with per-criterion pass/fail. Inline comment: # Per Physical AI Adaptation of § 312.20 — eligibility encompasses Physical AI component readiness.
3. check_duplicate_enrollment(self, patient_id: str) -> dict — calls federation/site_enrollment.py→ ConflictResolutionEngine.resolve_conflict(). Queries all federated sites via secure channel. Returns conflict check result (no duplicate for PAT-2026-0042).
4. verify_protocol_compliance(self, protocol: dict) -> dict — calls agentic-ai/examples-agentic-ai/06_protocol_rag_compliance_agent.py patterns. Protocol Compliance Agent performs RAG-based verification against ICH E6(R3) § 2.8 (6 Physical AI consent elements), Physical AI Adaptation of § 312.23 (IND content for robot profiles), Physical AI Adaptation of § 50.25 (8 basic + additional elements). Validates consent form includes physical AI disclosures: robot types (da Vinci Xi classified SURGICAL_ROBOT per § 312.401, Franka Panda classified COBOT per § 312.401), AI-assisted decision making, digital twin data retention, emergency manual override per § 50.30.
5. generate_consent(self, patient_id: str, site_id: str) -> ConsentRecord — calls regulatory/irb-management/irb_protocol_manager.py → generates site-specific consent form with Physical AI Appendix. Validates against Physical AI Adaptation of § 50.25 Additional Elements: robotic procedure descriptions, autonomy levels (0-4), AI-specific risks per ICH E6(R3) § 2.8.5(f), non-robotic alternatives per § 2.8.5(e), right to request full human control. Creates ConsentRecord with physical_ai_appendix_included=True, robot_types_disclosed=["da Vinci Xi", "Franka Panda"], autonomy_levels_disclosed=True, override_rights_disclosed=True. Consent documentation per Physical AI Adaptation of § 50.27 includes Physical AI System Summary section.
6. validate_gcp(self, enrollment_docs: dict) -> dict — calls regulatory/ich-gcp/gcp_compliance_checker.py → real-time GCP check. Validates per ICH E6(R3) § 2.1 (investigator qualified for Physical AI systems per § 2.1.2), § 2.4 (IRB communication), § 2.2.3 (adequate staff and facilities for robotic procedures).
7. submit_for_irb_review(self, consent_docs: dict) -> dict — validates per § 50.31 (IRB Review of Physical AI Investigations): IRB must evaluate Physical AI safety profiles, USL scores, cybersecurity assessments, human oversight protocols. Records RegulatoryEvent with cfr_section="§ 50.31".
8. randomize_patient(self) -> TreatmentArm — calls federation/site_enrollment.py → SiteEnrollmentManager.randomize_patient(). Per ICH E6(R3) § 2.7 (Randomisation in Physical AI Trials), executes stratified block randomization ensuring blinding integrity in automated systems (§ 2.7.2). Assigns Arm A (Experimental): robotic-assisted thoracoscopic lobectomy + pembrolizumab 200mg q3w × 2 years. Stratification factors: stage, PD-L1 level, ECOG, smoking history.
9. upgrade_access(self, patient_id: str, treatment_arm: TreatmentArm) -> dict — calls privacy/access-control/access_control_manager.py. Upgrades access per Physical AI Adaptation of § 312.57: PI and sub-investigator get read-write, robot operator gets procedure-specific access. Logs PATIENT_ENROLLED audit entry with electronic signature (21 CFR Part 11).
10. run(self, patient_state: PatientJourneyState) -> PatientJourneyState — orchestrates all methods, advances stage to ENROLLMENT, status to ENROLLED then RANDOMIZED. Records enrollment_day = 0. Returns updated state.
File 2: patient-journey/diagrams/stage_02/perspective_a_timeline.txt
* Timeline showing Stage 1 [DONE], Stage 2 [ACTIVE], Stages 3–10 [PENDING]
* Stage 1 milestones: PHI cleared, FHIR mapped, DICOM valid
* Stage 2 milestones: Eligible (all criteria met), Consented (Physical AI appendix), IRB approved, Randomized Arm A
* Cumulative: 44 days elapsed | 2 of 10 stages (1 done, 1 active) | Status: RANDOMIZED
File 3: patient-journey/diagrams/stage_02/perspective_b_regulatory.txt
* Regulatory matrix showing Stage 1 [✓] and Stage 2 [→] with all applicable sections
* Cumulative: 19 regulatory sections addressed (7 from S1 + 12 from S2)
File 4: patient-journey/diagrams/stage_02/perspective_c_clinical.txt
* Dashboard updated: Stage 2/10, Status RANDOMIZED, Arm A assigned, Consent OBTAINED v1
* Physical AI systems still pending
* Modules active: 11 of 51
File 5: tests/test_patient_journey/test_stage_02_enrollment.py (~200-250 lines)
* Fixtures: enrolled_patient_state() (state from Stage 1 completion), trial_config() (protocol YAML-equivalent dict with inclusion/exclusion criteria), mock_eligibility_criteria()
* Tests (at least 13):
    * test_eligibility_all_criteria_met — PAT-2026-0042 passes all inclusion, fails no exclusion
    * test_eligibility_fails_low_pdl1 — patient with PD-L1 < 50% rejected
    * test_eligibility_fails_prior_immunotherapy — exclusion triggered
    * test_duplicate_check_no_conflict — no duplicate across sites
    * test_protocol_compliance_verified — RAG agent confirms compliance
    * test_consent_includes_six_ai_elements — consent doc contains all ICH E6(R3) § 2.8.5 elements (a)-(f)
    * test_consent_record_physical_ai_fields — physical_ai_appendix, robot_types, autonomy, override all True/populated
    * test_consent_documentation_system_summary — Physical AI System Summary per § 50.27
    * test_irb_review_physical_ai — § 50.31 IRB review includes USL scores and safety profiles
    * test_gcp_validation_passes — enrollment docs pass GCP checks per ICH E6(R3) § 2.1–2.4
    * test_randomization_assigns_arm — returns valid TreatmentArm enum per § 2.7
    * test_access_upgrade_creates_audit — audit entry for enrollment logged per § 312.57
    * test_enrollment_run_end_to_end — full pipeline from eligible patient to randomized
Commit message:
Add Stage 2: Eligibility screening & enrollment (Day -14 to 0)

Implement enrollment orchestrator with eligibility checking per Physical AI
Adaptation of § 312.20, informed consent with 6 ICH E6(R3) § 2.8.5 elements
and § 50.25 Physical AI Additional Elements, IRB review per § 50.31,
stratified randomization per § 2.7, and access provisioning. 3 cumulative
progress diagrams. 13 tests.

COMMIT 3 — STAGE 3: DIGITAL TWIN CONSTRUCTION (Day 0 to Day 7)
Clinical context: With the patient enrolled, a patient-specific digital twin is constructed from baseline imaging and clinical data. Multiple tumor growth models are calibrated, treatment arms simulated, toxicity predicted, and the twin validated per ASME V&V 40.
Governing regulations:
* ICH E6(R3) § 1.4 (Simulation and Digital Twin Requirements)
* ICH E6(R3) § 1.4.1 (Simulation Frameworks — Isaac Lab, MuJoCo, Gazebo, PyBullet)
* ICH E6(R3) § 1.4.2 (Digital Twin Systems — patient-specific modeling requirements)
* Physical AI Adaptation of § 312.21 (Phases of Investigation — simulation-based Phase 0 validation)
* Physical AI Adaptation of § 312.23 (IND Content — simulation data and digital twin specifications)
* § 312.402 (Physical AI System Validation Requirements — twin accuracy thresholds)
* § 50.32 (Ongoing Consent and Subject Notification — twin creation disclosure)
Files to create:
File 1: patient-journey/stage_03_digital_twin.py (~450-500 lines) Class DigitalTwinOrchestrator with methods:
1. __init__(self, patient_state: PatientJourneyState) — accepts enrolled patient state
2. create_tumor_twin(self) -> dict — calls digital-twins/patient-modeling/tumor_twin_pipeline.py → TumorTwinPipeline.create_pipeline(), PatientClinicalData populated from state (age 58, sex F, grade G2, stage IIIB, markers {pdl1: 0.65, tmb: 14, egfr: WT, alk: neg}), PatientDigitalTwin created per ICH E6(R3) § 1.4.2. Fits multiple growth models: ReactionDiffusionModel (spatial heterogeneity), LogisticGrowthModel (K=85 cm³, r=0.023/day), GompertzGrowthModel (deceleration), MechanisticModel (immune dynamics). calibrate()fits to baseline CT: volume 42.3 cm³, proliferation 0.023/day, diffusion 0.0012 mm²/day.
3. model_toxicity(self) -> dict — calls digital-twins/examples-twins/02_multi_organ_toxicity_twin.pypatterns. PBPK model for pembrolizumab. Organ predictions: hepatic ALT/AST risk 12% (Grade ≥2), pulmonary pneumonitis 8% (elevated due to COPD), thyroid hypothyroidism 15%, dermatologic rash 18%. CTCAE v5.0 grading.
4. simulate_treatments(self) -> dict — calls digital-twins/treatment-simulation/treatment_simulator.py → TreatmentSimulator. Per Physical AI Adaptation of § 312.21 (simulation-based Phase 0), simulates 3 arms: Arm A (robotic lobectomy + pembro, predicted PFS 14.2 mo), Arm B (open thoracotomy + pembro, PFS 12.7 mo), Arm C (pembro mono, PFS 8.9 mo). predict_response(), compare_treatments(), monte_carlo_simulation() (10,000 iterations). Returns TreatmentResponse for assigned arm: PR predicted, volume change −47.2%, control probability 0.78.
5. calculate_doses(self) -> dict — calls tools/dose-calculator/dose_calculator.py → calc_bed() (72 Gy for potential adjuvant RT), calc_eqd2() (60 Gy), TCP = 0.74, NTCP lung = 0.08.
6. model_tumor_microenvironment(self) -> dict — calls digital-twins/examples-twins/04_tumor_microenvironment_immunotherapy_dt.py patterns. PatientTMEProfile with PD-L1 65%, TMB 14: T-cell infiltration moderate-high, checkpoint response favorable, TME subtype "inflamed". Simulates immune-tumor dynamics over 24 months. Predicts pseudoprogression window weeks 4-8.
7. simulate_adaptive_radiation(self) -> dict — calls digital-twins/examples-twins/03_adaptive_radiation_therapy_dt.py patterns. Dose accumulation modeling for potential adjuvant RT.
8. run_virtual_cohort_analysis(self) -> dict — calls digital-twins/examples-twins/05_virtual_trial_cohort_dt.py patterns. VirtualTrialSimulator with PAT-2026-0042's profile. Bayesian adaptive interim analysis, power calculations, efficacy posterior.
9. validate_twin(self) -> dict — calls digital-twins/examples-twins/06_dt_validation_verification.pypatterns. Per § 312.402: ASME V&V 40 verification (code correctness), validation (clinical agreement, RMSE 3.2 cm³ at 6 mo), applicability (surgical planning context). 95% prediction intervals calibrated against 200+ historical patients.
10. establish_realtime_sync(self) -> dict — calls digital-twins/examples-twins/01_realtime_dt_synchronization.py patterns. RealtimeDTSynchronizer with EKF state estimation. Sync rate configured: 30 Hz intraop, event-driven otherwise. State vector: tumor position, instrument positions, tissue deformation.
11. notify_patient_twin_creation(self) -> dict — per § 50.32, documents that digital twin was created from patient data, records what models are used, and ensures patient was previously informed per § 50.25 consent. Logs RegulatoryEvent with cfr_section="§ 50.32".
12. run(self, patient_state: PatientJourneyState) -> PatientJourneyState — orchestrates all, populates digital_twin field in state, advances stage to DIGITAL_TWIN_CONSTRUCTION. Records regulatory events for twin creation and validation.
File 2: patient-journey/diagrams/stage_03/perspective_a_timeline.txt
* Timeline: Stage 1 [DONE], Stage 2 [DONE], Stage 3 [ACTIVE], Stages 4–10 [PENDING]
* Cumulative milestones through Stage 3
* Day range: Day 0 to Day 7 | Cumulative: ~37 days
File 3: patient-journey/diagrams/stage_03/perspective_b_regulatory.txt
* Regulatory matrix: Stages 1-2 [✓], Stage 3 [→], Stages 4-10 [ ]
* Cumulative: ~26 regulatory sections addressed
File 4: patient-journey/diagrams/stage_03/perspective_c_clinical.txt
* Dashboard: Digital twin CALIBRATED, 4 growth models, V&V 40 passed
* Modules active: ~24 of 51
File 5: tests/test_patient_journey/test_stage_03_digital_twin.py (~250-300 lines)
* Tests (at least 14):
    * test_tumor_twin_creation — twin created with correct patient parameters
    * test_growth_model_calibration — volume 42.3 cm³, rate 0.023/day
    * test_multiple_growth_models_fitted — all 4 model types present per § 1.4.2
    * test_toxicity_prediction_organ_specific — hepatic, pulmonary, thyroid, derm risks returned
    * test_toxicity_ctcae_grading — all grades are valid CTCAE integers
    * test_treatment_simulation_three_arms — 3 arms simulated with PFS estimates per § 312.21 Phase 0
    * test_treatment_response_for_assigned_arm — PR with negative volume change
    * test_dose_calculation_bed_eqd2 — BED and EQD2 values physically reasonable
    * test_tme_subtype_classification — "inflamed" for PD-L1 65%
    * test_pseudoprogression_window — predicted between weeks 4-8
    * test_vv40_validation_passes — validation score meets § 312.402 threshold
    * test_realtime_sync_configuration — sync rate and state vector configured per § 1.4.1
    * test_patient_notification_twin_creation — § 50.32 ongoing consent documented
    * test_digital_twin_run_end_to_end — full run produces valid DigitalTwinState
Commit message:
Add Stage 3: Digital twin construction (Day 0 to 7)

Build patient-specific digital twin per ICH E6(R3) § 1.4.2, with tumor
growth modeling (4 models), toxicity prediction, treatment simulation
(Phase 0 per § 312.21), dose calculation, TME modeling, ASME V&V 40
validation per § 312.402, and ongoing consent notification per § 50.32.
3 cumulative progress diagrams. 14 tests.

COMMIT 4 — STAGE 4: ROBOT QUALIFICATION & SURGICAL PLANNING (Day 7 to Day 14)
Clinical context: The da Vinci Xi surgical robot and Franka Panda specimen cobot must be qualified via USL scoring, simulation benchmarks, safety validation, and hand-eye calibration before patient contact.
Governing regulations:
* § 312.401 (Physical AI System Classification for Clinical Investigations — SURGICAL_ROBOT, COBOT)
* § 312.402 (Physical AI System Validation Requirements — simulation benchmarks, accuracy thresholds)
* § 312.403 (Physical AI System Cybersecurity Requirements)
* § 312.404 (Physical AI Human Oversight Requirements — autonomy levels, override mechanisms)
* § 312.405 (Physical AI System Lifecycle Management — version control, PCCP)
* ICH E6(R3) § 1.5 (Unification Standard Level Framework — 10-point, 4-dimension scoring)
* ICH E6(R3) § 1.4.1 (Simulation Frameworks — Isaac Lab, MuJoCo cross-validation)
* § 50.30 (Physical AI System Safety Requirements — pre-procedure safety matrix, runtime monitoring, forbidden operations)
* ICH E6(R3) § 2.6 (Investigational Product and Physical AI Systems — accountability)
Files to create:
File 1: patient-journey/stage_04_robot_qualification.py (~400-450 lines) Class RobotQualificationOrchestrator with methods:
1. __init__(self, patient_state: PatientJourneyState, site_config: dict)
2. classify_robots(self) -> dict — per § 312.401, classifies da Vinci Xi as SURGICAL_ROBOT and Franka Panda as COBOT. Documents classification rationale per IMDRF risk categorization. Minimum USL thresholds: surgical ≥ 7.0, cobot ≥ 5.0 (per ICH E6(R3) § 1.5).
3. detect_frameworks(self, site_id: str) -> dict — calls unification/cross_platform_tools/framework_detector.py → FrameworkDetector. Per ICH E6(R3) § 1.4.1, auto-detects SITE-003: Isaac Sim 4.1 + MuJoCo 3.2.
4. convert_robot_models(self, robot_configs: list[dict]) -> dict — calls unification/simulation_physics/urdf_sdf_mjcf_converter.py. Da Vinci Xi: URDF → MJCF + USD. Franka Panda: URDF → MJCF + USD. Validates kinematic chain integrity per § 312.402.
5. score_surgical_robot(self) -> RobotQualification — calls unification/usl/surgical/usl_surgical_scoring.py and unification/usl/surgical/intuitive_davinci_usl.py. Per ICH E6(R3) § 1.5, 4-dimension scoring: Autonomy 6.8, Dexterity 9.2, Safety 8.5, Interoperability 7.1. Composite 7.9/10 → PASS (≥ 7.0). USL readiness: ADVANCED.
6. score_cobot(self) -> RobotQualification — calls unification/usl/cobots/usl_scoring_framework.pyand unification/usl/cobots/franka_panda_usl.py. Composite 7.2/10 → PASS (≥ 5.0). USL readiness: ADVANCED.
7. run_simulation_benchmarks(self) -> dict — calls tools/sim-job-runner/sim_job_runner.py. Per § 312.402, 100 procedural variations.
8. validate_cross_framework(self) -> dict — calls unification/simulation_physics/isaac_mujoco_bridge.py. Per ICH E6(R3) § 1.4.1, bidirectional state sync. Max state divergence: 0.3mm positional, 0.02 Nm force.
9. validate_safety(self) -> dict — per § 50.30, calls examples-new/01_realtime_safety_monitoring.pypatterns. IEC 80601-2-77: force limits (15N tip, 5N lateral), workspace boundaries, e-stop latency <50ms. Also calls agentic-ai/examples-agentic-ai/05_safety_constrained_agent_executor.py patterns for formal verification per § 312.404.
10. validate_cybersecurity(self) -> dict — per § 312.403, validates encrypted communication, access control, intrusion detection, firmware integrity.
11. calibrate_hand_eye(self) -> dict — calls examples-new/04_hand_eye_calibration_registration.py → PatientRegistration. Tsai-Lenz calibration (reprojection error 0.12mm), Arun SVD registration (FRE 0.8mm).
12. check_deployment_readiness(self) -> dict — calls tools/deployment-readiness/deployment_readiness.py. Per § 312.405, ONNX model validation, IEC 62304 lifecycle checks. 47/47 items passed.
13. run(self, patient_state: PatientJourneyState) -> PatientJourneyState — orchestrates all, populates robot_qualifications, advances stage to ROBOT_QUALIFICATION, updates status to SURGERY_SCHEDULED.
File 2: patient-journey/diagrams/stage_04/perspective_a_timeline.txt
* Stages 1-3 [DONE], Stage 4 [ACTIVE], Stages 5-10 [PENDING]
* New milestones: Da Vinci Xi USL 7.9, Franka Panda USL 7.2, safety validated, cybersecurity cleared
File 3: patient-journey/diagrams/stage_04/perspective_b_regulatory.txt
* Stages 1-3 [✓], Stage 4 [→] with all Subpart J sections (§ 312.401-405)
* Cumulative: ~37 regulatory sections
File 4: patient-journey/diagrams/stage_04/perspective_c_clinical.txt
* Dashboard: Both robots qualified and deployment-ready
* Modules active: ~36 of 51
File 5: tests/test_patient_journey/test_stage_04_robot_qualification.py (~250-300 lines)
* Tests (at least 15):
    * test_robot_classification_surgical — da Vinci Xi classified SURGICAL_ROBOT per § 312.401
    * test_robot_classification_cobot — Franka Panda classified COBOT per § 312.401
    * test_framework_detection — Isaac Sim + MuJoCo detected per § 1.4.1
    * test_model_conversion_davinci — URDF → MJCF + USD successful
    * test_usl_surgical_scoring — da Vinci composite 7.9, ADVANCED readiness per § 1.5
    * test_usl_surgical_above_threshold — 7.9 ≥ 7.0 surgical minimum
    * test_usl_cobot_scoring — Franka composite 7.2, ADVANCED readiness per § 1.5
    * test_usl_fail_below_threshold — score < threshold fails
    * test_simulation_benchmarks_run — 100 variations per § 312.402
    * test_cross_framework_divergence — within tolerance per § 1.4.1
    * test_safety_pre_procedure_matrix — § 50.30 pre-procedure safety matrix populated
    * test_safety_forbidden_operations — § 50.30 forbidden operations enforced
    * test_cybersecurity_validated — § 312.403 requirements met
    * test_deployment_readiness_lifecycle — § 312.405 lifecycle documented
    * test_robot_qualification_run_end_to_end — full run with regulatory events
Commit message:
Add Stage 4: Robot qualification & surgical planning (Day 7 to 14)

Implement robot qualification per Physical AI Subpart J: classification
(§ 312.401), validation (§ 312.402), cybersecurity (§ 312.403), human
oversight (§ 312.404), lifecycle (§ 312.405). USL scoring per ICH E6(R3)
§ 1.5 for da Vinci Xi (7.9 ADVANCED) and Franka Panda (7.2 ADVANCED).
Safety matrix per § 50.30. 3 cumulative progress diagrams. 15 tests.

COMMIT 5 — STAGE 5: SURGERY — ACTIVE ROBOT OPERATIONS (Day 14)
Clinical context: Operative day. Robotic-assisted thoracoscopic right upper lobectomy with mediastinal lymph node dissection. Real-time safety monitoring, sensor fusion, shared autonomy, digital twin overlay, and specimen chain-of-custody.
Governing regulations:
* § 50.30 (Runtime Safety Monitoring — force limits, workspace boundaries, physiological monitoring)
* § 50.30 (Task-Order Lifecycle — pre-check → active → pause → complete → abort)
* § 50.30 (Forbidden Operations — autonomous operation without human override capability)
* § 312.404 (Human Oversight — surgeon retains ultimate authority, autonomy level documentation)
* Physical AI Adaptation of § 312.62 (Investigator Recordkeeping — robot telemetry, AI decision logs)
* ICH E6(R3) § 2.3 (Medical Care — physician responsibility for robotic procedures)
* ICH E6(R3) § 2.12 (Investigator Oversight of Physical AI Systems)
* ICH E6(R3) § 2.10 (Safety Reporting — 5 Physical AI AE categories)
* Physical AI Adaptation of § 312.57 (Recordkeeping — 21 CFR Part 11 electronic records for robotic procedures)
Files to create:
File 1: patient-journey/stage_05_surgery.py (~500-550 lines) Class SurgeryOrchestrator with methods:
1. __init__(self, patient_state: PatientJourneyState)
2. initialize_ros2_deployment(self) -> dict — calls examples-new/03_ros2_surgical_deployment.pypatterns. Per § 50.30 Task-Order Lifecycle: IDLE → SETUP → DOCKED → READY.
3. execute_pre_procedure_safety_matrix(self) -> dict — per § 50.30, validates all safety prerequisites.
4. activate_surgical_digital_twin(self) -> dict — calls digital-twins/clinical-integration/clinical_dt_interface.py. Per ICH E6(R3) § 1.4.2, AR overlay of tumor boundaries, vessels, lymph nodes.
5. start_realtime_sync(self) -> dict — EKF state estimation at 30 Hz.
6. run_sensor_fusion(self) -> dict — calls examples-new/02_sensor_fusion_intraoperative.py patterns. Stereo endoscope, RGBD, instrument tracking, force/torque.
7. manage_shared_autonomy(self, autonomy_level: int = 2) -> dict — per § 312.404 and § 50.30, Level 2: surgeon leads, AI assists. Forbidden Operations: autonomous tissue cutting without surgeon confirmation.
8. monitor_safety_realtime(self, procedure_events: list[dict]) -> dict — per § 50.30, 1 kHz monitoring. Records T+45 min force spike to 12.1N — warning issued per ICH E6(R3) § 2.10.1(a), resolved in 200ms.
9. run_sim_vs_real(self) -> dict — per ICH E6(R3) § 2.12.3(c), digital twin accuracy assessment. Deviation threshold 5mm.
10. handle_specimens(self, specimens: list[dict]) -> dict — per § 312.62 and § 312.57, Franka Panda specimen handling with 21 CFR Part 11 audit trail.
11. record_surgical_outcome(self) -> SurgicalRecord — day 14, 168 min, 85 mL EBL, negative margins, 18 LN sampled, usl_score=7.9, autonomy_level=2.
12. perform_investigator_oversight_review(self) -> dict — per ICH E6(R3) § 2.12.3, systematic review of items (a)-(e).
13. coordinate_agents(self) -> dict — MCP server at ROBOT_PROCEDURE conformance level per § 50.33.
14. run(self, patient_state: PatientJourneyState) -> PatientJourneyState — orchestrates full procedure. Updates mcp_conformance_level to ROBOT_PROCEDURE.
File 2: patient-journey/diagrams/stage_05/perspective_a_timeline.txt
* Stages 1-4 [DONE], Stage 5 [ACTIVE], Stages 6-10 [PENDING]
* New milestones: Surgery complete, 168 min, negative margins, 18 LN
File 3: patient-journey/diagrams/stage_05/perspective_b_regulatory.txt
* Cumulative: ~47 regulatory sections
File 4: patient-journey/diagrams/stage_05/perspective_c_clinical.txt
* Dashboard: Surgery complete, tumor volume → 0 cm³, MCP level ROBOT_PROCEDURE
File 5: tests/test_patient_journey/test_stage_05_surgery.py (~300-350 lines)
* Tests (at least 16):
    * test_ros2_state_machine_task_order_lifecycle
    * test_pre_procedure_safety_matrix
    * test_surgical_twin_activation
    * test_realtime_sync_rate
    * test_sensor_fusion_pipeline
    * test_shared_autonomy_level_2_human_oversight
    * test_forbidden_operations_enforced
    * test_autonomy_level_range
    * test_safety_monitoring_force_within_limits
    * test_safety_monitoring_force_warning_logged
    * test_sim_vs_real_deviation_twin_accuracy
    * test_specimen_chain_of_custody_part_11
    * test_surgical_record_usl_and_autonomy
    * test_investigator_oversight_review
    * test_mcp_conformance_robot_procedure
    * test_surgery_run_end_to_end
Commit message:
Add Stage 5: Surgery — active robot operations (Day 14)

Implement surgical orchestrator with § 50.30 pre-procedure safety matrix,
task-order lifecycle, runtime monitoring at 1kHz, and forbidden operations.
Human oversight per § 312.404, investigator review per ICH E6(R3) § 2.12.3,
safety reporting per § 2.10.1, Level 2 shared autonomy, specimen
chain-of-custody per § 312.57/Part 11. 3 cumulative progress diagrams.
16 tests.

COMMIT 6 — STAGE 6: POST-OPERATIVE RECOVERY (Day 14 to Day 28)
Clinical context: Patient recovering from surgery. Digital twin transitions to event-driven sync. Pathology results integrated. Post-operative adverse events (atrial fibrillation) monitored and reported.
Governing regulations:
* Physical AI Adaptation of § 312.32 (IND Safety Reporting — Physical AI-specific AE categories)
* ICH E6(R3) § 2.10 (Safety Reporting — 5 Physical AI AE categories)
* ICH E6(R3) § 2.3.2 (Adverse event monitoring by qualified physician)
* Physical AI Adaptation of § 312.64 (Investigator Reports)
* § 50.32 (Ongoing Consent — notification of significant new findings)
* § 50.30 (Post-Procedure Requirements)
Files to create:
File 1: patient-journey/stage_06_recovery.py (~300-350 lines) Class RecoveryOrchestrator with methods:
1. __init__(self, patient_state: PatientJourneyState)
2. transition_dt_sync(self) -> dict — transitions from 30 Hz to event-driven per § 50.30 Post-Procedure Requirements.
3. monitor_recovery_metrics(self, daily_data: list[dict]) -> dict — Day 1: drain 210 mL → continue. Day 3: drain 45 mL → remove. Day 5: CXR clear, discharge planning.
4. integrate_pathology(self, pathology_report: dict) -> dict — pT2aN2M0, margins negative (8mm), 3/18 LN+, PD-L1 72% confirmed. Recurrence risk 35% at 18 months.
5. track_adverse_events(self, events: list[dict]) -> list[AdverseEvent] — Day 16: atrial fibrillation (Grade 2), reported to IRB, not FDA (not device-related per causality assessment).
6. assess_physical_ai_causality(self, ae: AdverseEvent) -> dict — per ICH E6(R3) § 2.10.1, evaluates all 5 Physical AI AE categories (a)-(e). Conclusion: unrelated.
7. validate_ae_compliance(self, adverse_events: list[AdverseEvent]) -> dict — per § 312.64, validates timely reporting.
8. run(self, patient_state: PatientJourneyState) -> PatientJourneyState — orchestrates all, advances to RECOVERY.
File 2: patient-journey/diagrams/stage_06/perspective_a_timeline.txt File 3: patient-journey/diagrams/stage_06/perspective_b_regulatory.txt File 4: patient-journey/diagrams/stage_06/perspective_c_clinical.txt
* All cumulative through Stage 6. Dashboard shows: 1 AE (Grade 2 AF), pathology integrated, recurrence risk 35%.
File 5: tests/test_patient_journey/test_stage_06_recovery.py (~200 lines)
* Tests (at least 11):
    * test_dt_sync_transition_post_procedure
    * test_drain_output_recommendations
    * test_pathology_integration
    * test_recurrence_risk_model
    * test_adverse_event_creation
    * test_ae_severity_moderate
    * test_physical_ai_causality_five_categories
    * test_ae_unrelated_to_device
    * test_ae_irb_reporting_timeline
    * test_ae_compliance_check
    * test_recovery_run_end_to_end
Commit message:
Add Stage 6: Post-operative recovery (Day 14 to 28)

Implement recovery orchestrator with § 50.30 post-procedure transition,
adverse event tracking with Physical AI causality assessment against
5 categories per ICH E6(R3) § 2.10.1, IND safety reporting per § 312.32,
pathology integration, and GCP-compliant reporting per § 312.64.
3 cumulative progress diagrams. 11 tests.

COMMIT 7 — STAGE 7: ADJUVANT IMMUNOTHERAPY (Day 28 to Month 24)
Clinical context: 35 cycles of pembrolizumab over 2 years. Cycle-by-cycle monitoring, toxicity tracking (hypothyroidism at cycle 6, rash at cycle 12), adaptive treatment decisions via agentic AI, and continuous digital twin updates.
Governing regulations:
* Physical AI Adaptation of § 312.33 (Annual Reports — Physical AI system performance data)
* Physical AI Adaptation of § 312.56 (Review of Ongoing Investigations)
* Physical AI Adaptation of § 312.30 (Protocol Amendments)
* § 312.405 (Physical AI System Lifecycle Management)
* ICH E6(R3) § 2.5 (Compliance with Protocol)
* ICH E6(R3) § 2.12.4 (Participant Notification of Changes)
* ICH E6(R3) § 3.1 (Sponsor Quality Management)
* § 50.32 (Ongoing Consent — notification of new toxicity findings)
Files to create:
File 1: patient-journey/stage_07_immunotherapy.py (~450-500 lines) Class ImmunotherapyOrchestrator with methods:
1. __init__(self, patient_state: PatientJourneyState, treatment_protocol: dict)
2. initialize_treatment(self) -> dict — Pembrolizumab 200mg IV q3w, 35 planned cycles. PK/PD models.
3. execute_cycle(self, cycle_number: int, labs: dict, imaging: dict | None = None) -> TreatmentCycle — per ICH E6(R3) § 2.5.
4. track_cumulative_toxicity(self, cycles: list[TreatmentCycle]) -> dict — Cycle 6: hypothyroidism (Grade 1). Cycle 12: rash (Grade 1). Per § 50.32, patient notified.
5. update_twin_at_imaging(self, imaging_data: dict, cycle: int) -> dict — Risk: 35→28→18→12→8%.
6. run_adaptive_agent(self, cycle: int, clinical_data: dict) -> dict — per § 312.404 human oversight.
7. generate_annual_report(self) -> dict — per § 312.33, Physical AI system performance data.
8. monitor_regulatory_changes(self) -> dict — per § 312.56.
9. run(self, patient_state: PatientJourneyState) -> PatientJourneyState — iterates all 35 cycles. Advances to IMMUNOTHERAPY.
File 2: patient-journey/diagrams/stage_07/perspective_a_timeline.txt File 3: patient-journey/diagrams/stage_07/perspective_b_regulatory.txt File 4: patient-journey/diagrams/stage_07/perspective_c_clinical.txt
* Cumulative through Stage 7. Dashboard: 35 cycles, 3 AEs, recurrence risk declining.
File 5: tests/test_patient_journey/test_stage_07_immunotherapy.py (~300-350 lines)
* Tests (at least 16):
    * test_treatment_initialization
    * test_tme_post_surgical_enhancement
    * test_single_cycle_execution
    * test_cycle_labs_recorded
    * test_imaging_timepoint_ned
    * test_hypothyroidism_cycle_6
    * test_ongoing_consent_notification_cycle_6
    * test_rash_cycle_12
    * test_cumulative_toxicity_tracking
    * test_recurrence_risk_decreasing
    * test_adaptive_agent_human_oversight
    * test_simulation_agent_rash_whatif
    * test_annual_report_physical_ai_data
    * test_regulatory_monitoring
    * test_treatment_completion_35_cycles
    * test_immunotherapy_run_end_to_end
Commit message:
Add Stage 7: Adjuvant immunotherapy (Day 28 to Month 24)

Implement immunotherapy orchestrator with 35-cycle management per ICH
E6(R3) § 2.5, cumulative toxicity tracking with § 50.32 ongoing consent
notification, adaptive agentic AI with § 312.404 human oversight,
IND annual report per Physical AI Adaptation of § 312.33 including
system performance data, and § 312.56 regulatory monitoring.
3 cumulative progress diagrams. 16 tests.

COMMIT 8 — STAGE 8: FEDERATED DATA CONTRIBUTION (Continuous)
Clinical context: Patient's de-identified data contributes to federated learning across all trial sites throughout the trial, without raw data ever leaving the site.
Governing regulations:
* § 50.33 (Data Protection — MCP-PAI servers, HIPAA, differential privacy)
* Physical AI Adaptation of § 312.52 (Transfer of Obligations to CRO)
* Physical AI Adaptation of § 312.120 (Foreign Clinical Studies)
* Physical AI Adaptation of § 312.130 (Availability for Public Disclosure)
* ICH E6(R3) § 3.1.1 (Critical to Quality Factors)
* Physical AI Adaptation of § 312.58 (Inspection of Sponsor's Records)
Files to create:
File 1: patient-journey/stage_08_federation.py (~350-400 lines) Class FederationOrchestrator with methods:
1. __init__(self, patient_state: PatientJourneyState, federation_config: dict)
2. train_local_models(self, patient_data: dict) -> dict — per § 50.33, trains without exposing raw data.
3. apply_differential_privacy(self, model_updates: dict) -> dict — ε=1.0, δ=1e-5, gradient clipping max_norm=1.0.
4. execute_secure_aggregation(self, site_updates: list[dict]) -> dict — SMPC with additive secret sharing.
5. run_federation_round(self, round_number: int) -> FederationContribution
6. compute_federated_analytics(self) -> dict — KM PFS curve, Cox PH, without sharing raw data.
7. generate_dsmb_report(self) -> dict — per § 312.33, 0 device-related events.
8. monitor_site_performance(self) -> dict — per § 312.56, data quality 97.3%.
9. maintain_audit_trail(self) -> dict — per § 312.58, hash-chained audit.
10. run(self, patient_state: PatientJourneyState, total_rounds: int = 70) -> PatientJourneyState — ~70 rounds. Advances to FEDERATION.
File 2: patient-journey/diagrams/stage_08/perspective_a_timeline.txt File 3: patient-journey/diagrams/stage_08/perspective_b_regulatory.txt File 4: patient-journey/diagrams/stage_08/perspective_c_clinical.txt
* Cumulative through Stage 8. Dashboard: 70 federation rounds, ε budget tracked.
File 5: tests/test_patient_journey/test_stage_08_federation.py (~250 lines)
* Tests (at least 13):
    * test_local_model_training_no_data_exposure
    * test_differential_privacy_epsilon
    * test_gradient_clipping
    * test_secure_aggregation_mcp_conformance
    * test_federation_round_execution
    * test_federation_strategy_selection
    * test_federated_kaplan_meier_no_raw_data
    * test_federated_cox_ph
    * test_dsmb_safety_report_physical_ai
    * test_site_performance_metrics
    * test_audit_trail_hash_chained
    * test_70_rounds_executed
    * test_federation_run_end_to_end
Commit message:
Add Stage 8: Federated data contribution (continuous)

Implement federation orchestrator with § 50.33 data protection (DP
epsilon=1.0, SMPC, MCP-PAI conformance), federated analytics per
§ 312.130, DSMB reporting per § 312.33 with Physical AI safety data,
hash-chained audit per § 312.58, and site monitoring per § 312.56.
3 cumulative progress diagrams. 13 tests.

COMMIT 9 — STAGE 9: TREATMENT COMPLETION & SURVEILLANCE (Month 24 to Month 36)
Clinical context: Pembrolizumab course completed (35/35 cycles). Patient enters active surveillance with periodic imaging and labs. Digital twin transitions to recurrence detection mode.
Governing regulations:
* Physical AI Adaptation of § 312.85 (Phase 4 Studies)
* Physical AI Adaptation of § 312.87 (Active Monitoring)
* Physical AI Adaptation of § 312.88 (Safeguards for Patient Safety)
* ICH E6(R3) § 2.11 (Premature Termination or Suspension)
* § 50.32 (Ongoing Consent — notification at treatment completion)
* ICH E6(R3) § 2.9 (Records and Reports)
Files to create:
File 1: patient-journey/stage_09_surveillance.py (~300-350 lines) Class SurveillanceOrchestrator with methods:
1. __init__(self, patient_state: PatientJourneyState)
2. record_treatment_completion(self) -> dict — CR, 35/35 cycles, per § 2.9 and § 50.32.
3. transition_to_surveillance_twin(self) -> dict — per § 1.4.2, recurrence detection mode.
4. process_surveillance_imaging(self, imaging_results: list[dict]) -> list[ImagingTimepoint] — Month 30: risk 5%. Month 36: risk 3%.
5. monitor_long_term_safety(self) -> dict — per § 312.88.
6. collect_follow_up_data(self, visit_data: list[dict]) -> dict — per § 2.9, PROs (EORTC QLQ-C30 + LC13).
7. run(self, patient_state: PatientJourneyState) -> PatientJourneyState — advances to SURVEILLANCE.
File 2: patient-journey/diagrams/stage_09/perspective_a_timeline.txt File 3: patient-journey/diagrams/stage_09/perspective_b_regulatory.txt File 4: patient-journey/diagrams/stage_09/perspective_c_clinical.txt
* Cumulative through Stage 9. Dashboard: CR, event-free, risk 3%.
File 5: tests/test_patient_journey/test_stage_09_surveillance.py (~200 lines)
* Tests (at least 10):
    * test_treatment_completion_cr
    * test_all_35_cycles_completed
    * test_patient_outcome_censored
    * test_ongoing_consent_completion_notification
    * test_surveillance_twin_transition
    * test_imaging_schedule
    * test_recurrence_risk_declining
    * test_long_term_safety_monitoring
    * test_physical_ai_long_term_outcomes
    * test_surveillance_run_end_to_end
Commit message:
Add Stage 9: Treatment completion & surveillance (Month 24 to 36)

Implement surveillance orchestrator with treatment completion per ICH
E6(R3) § 2.9, § 50.32 ongoing consent notification, digital twin
transition per § 1.4.2, active monitoring per § 312.87, long-term
safety per § 312.88, and Phase 4 outcomes per § 312.85.
3 cumulative progress diagrams. 10 tests.

COMMIT 10 — STAGE 10: TRIAL CLOSEOUT & REGULATORY SUBMISSION (Month 36+) + MASTER ORCHESTRATOR
Clinical context: Patient completes follow-up. Data locked, final de-identification sweep, regulatory submission package generated, GCP audit finalized, contribution to trial results calculated.
Governing regulations:
* Physical AI Adaptation of § 312.38 (Withdrawal of IND)
* Physical AI Adaptation of § 312.44 (Termination)
* Physical AI Adaptation of § 312.130 (Public Disclosure)
* Physical AI Adaptation of § 312.57 (Recordkeeping)
* Physical AI Adaptation of § 312.68 (Inspection of Records)
* § 312.402 (Validation — final validation report)
* ICH E6(R3) § 2.9 (Records and Reports)
* ICH E6(R3) § 3.1.1 (Critical to Quality)
* § 50.33 (Data Protection — final de-identification verification)
Files to create:
File 1: patient-journey/stage_10_closeout.py (~350-400 lines) Class CloseoutOrchestrator with methods:
1. __init__(self, patient_state: PatientJourneyState)
2. lock_patient_data(self) -> dict — per § 312.57, HARD_LOCK with Part 11 electronic signatures.
3. final_deidentification_review(self) -> dict — per § 50.33, re-identification risk < 0.04%.
4. generate_regulatory_package(self) -> dict — per § 312.23, Clinical Study Report with device performance.
5. run_final_gcp_audit(self) -> dict — per § 2.9 and § 3.1.1, GCP COMPLIANT: PASS.
6. archive_physical_ai_data(self) -> dict — per § 312.57 and § 312.68.
7. calculate_trial_contribution(self) -> dict — Bayesian posterior P(experimental superior) = 0.97. Federated HR 0.62.
8. finalize_patient_record(self) -> dict — COMPLETED status.
9. run(self, patient_state: PatientJourneyState) -> PatientJourneyState — orchestrates all closeout.
File 2: patient-journey/master_journey.py (~400-450 lines) Class MasterJourneyOrchestrator with:
1. __init__(self, trial_protocol: dict)
2. create_initial_patient(self, referral_data: dict) -> PatientJourneyState
3. run_stage_01_prescreening(self, state) -> PatientJourneyState through run_stage_10_closeout(self, state) -> PatientJourneyState — 10 stage methods
4. run_full_journey(self, referral_data: dict) -> PatientJourneyState — all 10 stages sequentially
5. generate_journey_report(self, final_state: PatientJourneyState) -> dict — comprehensive report
Also include:
* STAGE_REGULATORY_MAP — dict mapping each PatientStage to governing regulatory sections from all three .tex files (full table as in original prompt)
* STAGE_MODULE_MAP — dict mapping each PatientStage to repository modules activated (full table as in original prompt)
* if __name__ == "__main__": block running PAT-2026-0042 through full journey
File 3: patient-journey/diagrams/stage_10/perspective_a_timeline.txt
* All 10 stages [DONE] — complete journey timeline from Day −30 to Month 36+
* Every milestone from every stage shown
File 4: patient-journey/diagrams/stage_10/perspective_b_regulatory.txt
* All 10 stages [✓] — complete regulatory compliance matrix
* Cumulative: 84+ regulatory sections fully addressed
File 5: patient-journey/diagrams/stage_10/perspective_c_clinical.txt
* Complete clinical dashboard: CR, event-free at 36 months, all systems nominal
File 6: tests/test_patient_journey/test_stage_10_closeout.py (~200 lines)
* Tests (at least 11):
    * test_data_lock_hard
    * test_data_lock_read_only
    * test_final_deidentification_clean
    * test_reidentification_risk_below_threshold
    * test_regulatory_package_physical_ai_data
    * test_final_validation_report
    * test_gcp_audit_pass_with_physical_ai
    * test_subpart_j_compliance
    * test_physical_ai_data_archived
    * test_patient_status_completed
    * test_closeout_run_end_to_end
File 7: tests/test_patient_journey/test_master_journey.py (~250-300 lines)
* Tests (at least 16):
    * test_master_orchestrator_creation
    * test_initial_patient_creation
    * test_stage_01_prescreening_runs through test_stage_10_closeout_runs — 10 stage tests
    * test_full_journey_end_to_end
    * test_journey_report_metrics
    * test_stage_regulatory_map_complete
    * test_stage_module_map_complete
Commit message:
Add Stage 10: Trial closeout (Month 36+) and master journey orchestrator

Implement closeout with data lock per § 312.57, final de-identification
per § 50.33, regulatory package per § 312.23 with Physical AI data,
GCP audit per ICH E6(R3) § 2.9, Subpart J compliance verification,
and Physical AI data archival per § 312.68. Master orchestrator wires
all 10 stages with STAGE_REGULATORY_MAP citing 84+ CFR sections and
STAGE_MODULE_MAP activating 43 of 51 modules. 3 cumulative progress
diagrams (complete journey). 27 tests.

COMMIT 11 — VERIFICATION, CROSS-VALIDATION & CHANGELOG
This is the rigorous quality assurance commit. It must verify that all 10 prior commits are correct and that all information across all commits corresponds to each other consistently.
Step 1: Lint check Run ruff check patient-journey/ tests/test_patient_journey/ and fix ALL errors.
Step 2: Format check Run ruff format patient-journey/ tests/test_patient_journey/ to auto-format all files.
Step 3: Run tests Run pytest tests/test_patient_journey/ -v and fix ALL failures.
Step 4: Cross-commit consistency verification Create a comprehensive verification test file that validates consistency across ALL 10 stages:
File 1: tests/test_patient_journey/test_cross_stage_consistency.py (~400-500 lines) This file rigorously tests that all 10 stage commits are internally consistent and correspond to each other:
Tests (at least 25):
* Timeline consistency:
    * test_stage_day_ranges_non_overlapping — verify Day ranges across all 10 stages don't conflict
    * test_stage_progression_chronological — stages execute in chronological order
    * test_total_timeline_day_minus30_to_month36 — full timeline spans ~1,126 days
* Patient state consistency:
    * test_patient_id_consistent_all_stages — PAT-2026-0042 throughout
    * test_demographics_immutable — age, sex, ethnicity never change
    * test_stage_transitions_sequential — PRESCREENING → ENROLLMENT → ... → CLOSEOUT
    * test_status_transitions_valid — no invalid status jumps
    * test_treatment_arm_set_once — Arm A assigned at Stage 2, never changes
* Clinical data consistency:
    * test_tumor_volume_trajectory — 42.3 cm³ → 0 (surgery) → 0 (surveillance)
    * test_biomarkers_match_across_stages — PD-L1 65% in enrollment matches twin
    * test_adverse_events_cumulative — Stage 6 AE list is subset of Stage 7 list
    * test_treatment_cycles_count_35 — exactly 35 cycles across immunotherapy
    * test_surgical_record_matches_robot_qualification — USL 7.9 from Stage 4 matches Stage 5
    * test_recurrence_risk_monotonically_decreasing — 35% → 28% → 18% → 12% → 8% → 5% → 3%
* Regulatory consistency:
    * test_all_stages_have_regulatory_citations — every stage file has inline § references
    * test_regulatory_map_covers_all_stages — STAGE_REGULATORY_MAP has all 10 stages
    * test_module_map_covers_all_stages — STAGE_MODULE_MAP has all 10 stages
    * test_consent_record_maintained — consent tracked from Stage 2 through closeout
    * test_audit_trail_grows_monotonically — audit entries only added, never removed
    * test_data_lock_progression — OPEN → SOFT_LOCK (optional) → HARD_LOCK at closeout
* Diagram consistency:
    * test_all_30_diagram_files_exist — 3 diagrams × 10 stages = 30 .txt files
    * test_diagrams_cumulative — Stage N diagrams contain all Stage N-1 information
    * test_timeline_diagrams_show_correct_done_active_pending — each stage's Perspective A correct
    * test_regulatory_diagrams_section_counts_increasing — cumulative sections increase
    * test_clinical_dashboards_reflect_state — module counts, AE counts match actual state
Step 5: Content verification Read every file in patient-journey/ and tests/test_patient_journey/ and verify:
* Every stage file (01-10) exists and has a complete orchestrator class with all specified methods
* Every test file exists and has all specified test functions
* patient_state.py has all enums, all dataclasses, and the PatientJourneyState master class
* master_journey.py imports and calls all 10 stage orchestrators, contains both maps
* All files follow repository header conventions
* All inline comments cite specific Physical AI regulatory sections
* All 30 diagram files exist in patient-journey/diagrams/stage_XX/
* No files from prior commits (1-10) were modified
Step 6: Update CHANGELOG.md Add new entry at top:
## [v2.6.0] - 2026-03-19

### Added
- **Patient Journey Orchestration Layer** (`patient-journey/`): Complete single-patient lifecycle through Physical AI oncology trial with full regulatory traceability
  - `patient_state.py`: Central data model with PatientJourneyState, 10-stage enum, Physical AI classification per § 312.401, USL readiness levels per ICH E6(R3) § 1.5, MCP conformance levels per § 50.33, ConsentRecord with Physical AI appendix tracking per § 50.25, and 14 dataclasses
  - `stage_01_prescreening.py`: PHI detection, de-identification per § 50.33, data harmonization, DICOM validation (Day -30 to -14)
  - `stage_02_enrollment.py`: Eligibility screening per § 312.20, informed consent with 6 Physical AI elements per ICH E6(R3) § 2.8.5 and § 50.25, IRB review per § 50.31, stratified randomization per § 2.7 (Day -14 to 0)
  - `stage_03_digital_twin.py`: Tumor twin per ICH E6(R3) § 1.4.2, 4 growth models, treatment simulation (Phase 0 per § 312.21), ASME V&V 40 validation per § 312.402, ongoing consent per § 50.32 (Day 0 to 7)
  - `stage_04_robot_qualification.py`: Physical AI Subpart J compliance — classification (§ 312.401), validation (§ 312.402), cybersecurity (§ 312.403), human oversight (§ 312.404), lifecycle (§ 312.405), USL scoring per ICH E6(R3) § 1.5, safety matrix per § 50.30 (Day 7 to 14)
  - `stage_05_surgery.py`: § 50.30 pre-procedure safety matrix, task-order lifecycle, runtime monitoring at 1kHz, forbidden operations, human oversight per § 312.404, investigator review per ICH E6(R3) § 2.12.3, safety reporting per § 2.10.1 (Day 14)
  - `stage_06_recovery.py`: Physical AI causality assessment against 5 categories per ICH E6(R3) § 2.10.1, IND safety reporting per § 312.32, § 50.30 post-procedure (Day 14 to 28)
  - `stage_07_immunotherapy.py`: 35-cycle management per ICH E6(R3) § 2.5, ongoing consent per § 50.32, IND annual report with Physical AI system data per § 312.33, regulatory monitoring per § 312.56 (Day 28 to Month 24)
  - `stage_08_federation.py`: § 50.33 data protection (DP, SMPC, MCP-PAI), federated analytics per § 312.130, hash-chained audit per § 312.58 (Continuous)
  - `stage_09_surveillance.py`: Active monitoring per § 312.87, long-term safety per § 312.88, digital twin lifecycle per ICH E6(R3) § 1.4.2 (Month 24 to 36)
  - `stage_10_closeout.py`: Data lock per § 312.57, final de-identification per § 50.33, regulatory package per § 312.23, Subpart J verification (§ 312.400-405), GCP audit per ICH E6(R3) § 2.9, Physical AI data archival per § 312.68 (Month 36+)
  - `master_journey.py`: End-to-end orchestrator with STAGE_REGULATORY_MAP (84+ CFR sections across 3 regulatory frameworks) and STAGE_MODULE_MAP (43 of 51 repository modules)
  - `diagrams/`: 30 text-based progress diagrams (3 perspectives × 10 stages) tracking timeline, regulatory compliance, and clinical status cumulatively
- **Patient Journey Test Suite** (`tests/test_patient_journey/`): 165+ tests covering all 10 stages, master orchestrator, cross-stage consistency, data model, and regulatory compliance

### Notes
- Regulatory traceability: Every stage cites specific Physical AI adaptations from 21 CFR Part 312 (64 sections), 21 CFR Part 50 (20 sections), and ICH E6(R3) (35+ subsections)
- Activates 43 of 51 existing repository modules (84%) across the patient lifecycle
- Pipeline processes ~2,400 automated events, ~8,500 audit entries, ~10.8M safety data points per patient
- 97% of workflow steps execute without human intervention; 3 human escalation gates
- All modules follow RESEARCH USE ONLY convention — not for clinical decision-making
Step 7: Update ruff.toml Add to [lint.per-file-ignores]:
"patient-journey/**/*.py" = ["F401", "F402"]
Commit message:
Verify and fix patient journey: lint, format, tests, changelog (v2.6.0)

Run ruff check/format on all patient-journey files, fix test failures,
add cross-stage consistency tests (25 tests verifying all 10 stages
correspond correctly), verify 30 diagram files, update CHANGELOG.md
with v2.6.0 entry, add ruff.toml ignore pattern.

COMMIT 12 — FINAL DELIVERABLE PACKAGE: COMPREHENSIVE VISUALIZATIONS, FDA COST-SAVINGS ANALYSIS & PHARMACEUTICAL INDUSTRY GUIDANCE
This is the capstone commit that produces a complete deliverable package for stakeholders: clinical trial observers, FDA reviewers, and pharmaceutical industry partners. It contains ALL Commit 11 verification files PLUS all new Commit 12 deliverables, organized in a clear directory structure that is easy to follow from start to finish.
Directory Structure for Commit 12
patient-journey/
├── deliverables/                              ← ALL Commit 12 outputs
│   ├── diagrams/
│   │   ├── perspective_a_complete_timeline.txt       ← Same 3 perspectives as stages
│   │   ├── perspective_b_complete_regulatory.txt
│   │   ├── perspective_c_complete_clinical.txt
│   │   ├── comprehensive_journey_map.txt             ← Additional comprehensive diagram
│   │   ├── regulatory_deep_dive.txt                  ← Additional in-depth diagram
│   │   └── clinical_decision_flowchart.txt            ← Additional in-depth diagram
│   ├── charts/
│   │   ├── chart_01_tumor_volume_trajectory.py        ← Plotly chart generator
│   │   ├── chart_02_treatment_timeline_gantt.py
│   │   ├── chart_03_adverse_event_waterfall.py
│   │   ├── chart_04_recurrence_risk_progression.py
│   │   ├── chart_05_usl_scoring_radar.py
│   │   ├── chart_06_regulatory_compliance_heatmap.py
│   │   ├── chart_07_module_activation_sunburst.py
│   │   ├── chart_08_federation_convergence.py
│   │   ├── chart_09_safety_monitoring_dashboard.py
│   │   └── chart_10_patient_outcome_kaplan_meier.py
│   ├── tables/
│   │   ├── table_stage_summary.txt                    ← Text table: all 10 stages summary
│   │   ├── table_adverse_events.txt                   ← Text table: all AEs with causality
│   │   ├── table_regulatory_sections.txt              ← Text table: 84+ sections by stage
│   │   ├── table_module_activation.txt                ← Text table: 43 modules by stage
│   │   ├── table_digital_twin_predictions.txt         ← Text table: twin predictions vs actuals
│   │   └── table_treatment_cycles.txt                 ← Text table: 35 cycles summary
│   ├── fda_cost_savings/
│   │   ├── fda_savings_analysis.txt                   ← Comprehensive cost/time/personnel estimates
│   │   └── fda_savings_methodology.txt                ← Methodology and assumptions
│   ├── guidance/
│   │   ├── field_observer_guide.txt                   ← What each output means
│   │   ├── patient_journey_walkthrough.txt            ← Start-to-finish narrative
│   │   ├── repository_output_glossary.txt             ← What every file in the repo means
│   │   └── pharmaceutical_industry_briefing.txt       ← Deliverable package for pharma
│   └── generate_all_deliverables.py                   ← Master script to generate all charts
Detailed Specifications

SECTION A: Three Standard Perspective Diagrams (Same types as Stages 1–10)
File 1: patient-journey/deliverables/diagrams/perspective_a_complete_timeline.txt (~100-120 lines)
* Complete horizontal ASCII timeline showing ALL 10 stages as [DONE]
* Every key milestone from every stage listed
* Full day/month markers from Day −30 through Month 36+
* Total elapsed time: ~1,126 days
* Final status: COMPLETED, CR, event-free at 36 months
* This is the definitive "at-a-glance" journey view
File 2: patient-journey/deliverables/diagrams/perspective_b_complete_regulatory.txt (~100-120 lines)
* Complete regulatory compliance matrix, all 10 stages [✓]
* Every regulatory section from all three frameworks listed by stage
* Summary counts: 30+ sections from 21 CFR 312, 15+ from 21 CFR 50, 20+ from ICH E6(R3)
* Total: 84+ sections fully satisfied
File 3: patient-journey/deliverables/diagrams/perspective_c_complete_clinical.txt (~100-120 lines)
* Final clinical dashboard with all terminal values
* Every metric at its final state

SECTION B: Three Additional Comprehensive/In-Depth Text Diagrams
File 4: patient-journey/deliverables/diagrams/comprehensive_journey_map.txt (~150-200 lines) A comprehensive bird's-eye-view journey map showing:
* Left-to-right flow of all 10 stages as connected boxes
* For EACH stage: inputs → processing steps → outputs → decisions
* Data flows between stages (what each stage passes to the next)
* Module activations per stage (which of the 51 modules fire)
* Human escalation gates (3 points where humans must intervene)
* This diagram is WIDE and COMPREHENSIVE — the single most informative diagram in the repository
* Shows the complete orchestration architecture
File 5: patient-journey/deliverables/diagrams/regulatory_deep_dive.txt (~150-200 lines) An in-depth regulatory traceability diagram showing:
* Three vertical swim lanes (one per regulatory framework: 21 CFR 312, 21 CFR 50, ICH E6(R3))
* Each section number mapped to the specific stage(s) where it is satisfied
* Cross-references between frameworks (e.g., § 312.401 classification feeds into § 50.30 safety matrix, which feeds into ICH E6(R3) § 2.12 oversight)
* Subpart J (§ 312.400-405) deep dive showing how each of the 5 Physical AI sections is satisfied across multiple stages
* New Subpart C (§ 50.30-34) deep dive
* ICH E6(R3) § 1.2-1.5 + § 2.8-2.12 deep dive
File 6: patient-journey/deliverables/diagrams/clinical_decision_flowchart.txt (~150-200 lines) An in-depth clinical decision flowchart showing:
* Every clinical decision point throughout the patient journey
* Decision diamonds with YES/NO branches
* For each decision: who decides (AI vs. human), what data feeds it, what happens on each branch
* The 3 human escalation events explicitly called out with their triggers and outcomes
* Adverse event decision tree (detect → grade → causality → report pathway)
* Treatment modification decision tree (toxicity → hold/reduce/continue)
* Digital twin decision points (when does the twin trigger an alert?)
* This is the most clinically detailed diagram — intended for treating physicians

SECTION C: Ten Colored Clinical Trial Plotly Charts
Each chart is a standalone Python file that generates a Plotly figure with color, interactivity, and clinical trial relevance. Each file follows the repository Plotly pattern from images/interactive/ (light mode only support, create_chart()function, HTML + PNG export). Each chart must use medically appropriate color schemes (e.g., red for adverse events, green for positive outcomes, blue for monitoring data).
File 7: patient-journey/deliverables/charts/chart_01_tumor_volume_trajectory.py (~150-200 lines)
* Chart type: Line chart with confidence bands
* Content: Tumor volume (cm³) over time from Day −30 to Month 36
* Baseline 42.3 cm³ → predicted decline during simulated treatment → surgical resection to 0 → surveillance at 0
* Digital twin predictions overlaid with actual trajectory
* Color-coded phases (pre-screening blue, treatment green, surveillance gold)
* Annotations: surgery day, each imaging timepoint, CR declaration
File 8: patient-journey/deliverables/charts/chart_02_treatment_timeline_gantt.py (~150-200 lines)
* Chart type: Gantt/timeline chart
* Content: All 10 stages as horizontal bars with their actual day ranges
* Color-coded by stage category (diagnostic=blue, treatment=red, monitoring=green, regulatory=purple)
* Key events as diamond markers: consent, randomization, surgery, AEs, treatment completion, data lock
* Overlapping stages shown (e.g., Federation spans multiple stages)
File 9: patient-journey/deliverables/charts/chart_03_adverse_event_waterfall.py (~150-200 lines)
* Chart type: Waterfall/swim lane chart
* Content: All adverse events plotted by onset day, duration, severity grade (color intensity), and organ system
* 3 AEs: AF (Grade 2, Day 16-23, cardiac), hypothyroidism (Grade 1, Cycle 6+, endocrine), rash (Grade 1, Cycle 12-14, dermatologic)
* Physical AI causality overlay (all categorized as "unrelated" per § 2.10.1)
* CTCAE color scale: Grade 1=yellow, Grade 2=orange, Grade 3+=red
File 10: patient-journey/deliverables/charts/chart_04_recurrence_risk_progression.py (~150-200 lines)
* Chart type: Area chart with stepped risk values
* Content: Recurrence risk over time: 35% (post-surgery) → 28% (6mo) → 18% (12mo) → 12% (18mo) → 8% (24mo) → 5% (30mo) → 3% (36mo)
* Digital twin confidence interval shown as shaded area
* Threshold lines for "high risk" (>20%) and "low risk" (<10%)
* Annotations at each imaging assessment point
File 11: patient-journey/deliverables/charts/chart_05_usl_scoring_radar.py (~150-200 lines)
* Chart type: Radar/spider chart (2 overlaid)
* Content: USL scores for da Vinci Xi and Franka Panda across 4 dimensions (Autonomy, Dexterity, Safety, Interoperability)
* Da Vinci Xi: [6.8, 9.2, 8.5, 7.1] composite 7.9
* Franka Panda: [5.8, 7.5, 7.8, 6.7] composite 7.2
* Threshold rings at 5.0 (cobot minimum) and 7.0 (surgical minimum)
* Per ICH E6(R3) § 1.5
File 12: patient-journey/deliverables/charts/chart_06_regulatory_compliance_heatmap.py (~150-200 lines)
* Chart type: Heatmap
* Content: 10 stages (columns) × 3 regulatory frameworks (rows), with cell values = number of sections addressed
* Color intensity proportional to regulatory burden per stage
* Marginal totals on edges
* Annotations showing specific section numbers in each cell
File 13: patient-journey/deliverables/charts/chart_07_module_activation_sunburst.py (~150-200 lines)
* Chart type: Sunburst chart
* Content: Inner ring: 10 stages. Outer ring: modules activated per stage.
* 43 of 51 modules shown active, 8 shown inactive (grayed)
* Color-coded by module domain (privacy=purple, digital-twins=blue, federation=green, unification=orange, regulatory=red, agentic-ai=teal)
File 14: patient-journey/deliverables/charts/chart_08_federation_convergence.py (~150-200 lines)
* Chart type: Multi-line chart
* Content: Federation metrics over 70 rounds: global model loss (decreasing), gradient norm (stabilizing), cumulative epsilon budget (increasing linearly)
* SITE-003 contribution highlighted
* Privacy budget threshold line (total ε=70)
File 15: patient-journey/deliverables/charts/chart_09_safety_monitoring_dashboard.py (~200-250 lines)
* Chart type: Multi-panel dashboard (2×2 subplots)
* Content:
    * Panel 1: Force readings during surgery (time series with 15N limit line, 12.1N spike highlighted)
    * Panel 2: Vital signs during surgery (HR, SpO2, BP — all stable)
    * Panel 3: Robot state machine transitions (IDLE → SETUP → DOCKED → READY → ACTIVE → COMPLETE)
    * Panel 4: Digital twin vs reality deviation (mm) during surgery (all <5mm threshold)
File 16: patient-journey/deliverables/charts/chart_10_patient_outcome_kaplan_meier.py (~150-200 lines)
* Chart type: Step function (KM curve style)
* Content: Simulated KM-style PFS curve for PAT-2026-0042 vs trial population
* Patient's event-free trajectory highlighted in bold
* Median PFS for each arm shown (Arm A: 14.2mo predicted, >36mo actual)
* Censoring marks at 36 months
* Hazard ratio annotation: HR 0.62 (0.48-0.81)

SECTION D: Text-Based Tables
File 17: patient-journey/deliverables/tables/table_stage_summary.txt (~60-80 lines)
┌──────┬───────────────────────────────────┬──────────────┬──────────┬───────────┬──────────┐
│Stage │ Name                              │ Day Range    │ Duration │ Tests     │ Modules  │
├──────┼───────────────────────────────────┼──────────────┼──────────┼───────────┼──────────┤
│  1   │ Pre-Screening & Referral Intake   │ Day -30 to -14│ 16 days  │ 15        │ 6        │
│  2   │ Eligibility Screening & Enrollment│ Day -14 to 0 │ 14 days  │ 13        │ 5        │
│ ... (all 10 stages)                                                                        │
│ 10   │ Trial Closeout                    │ Month 36+    │ varies   │ 27        │ 7        │
├──────┼───────────────────────────────────┼──────────────┼──────────┼───────────┼──────────┤
│TOTAL │                                   │ ~1,126 days  │ ~37 mo   │ 165+      │ 43 of 51 │
└──────┴───────────────────────────────────┴──────────────┴──────────┴───────────┴──────────┘
File 18: patient-journey/deliverables/tables/table_adverse_events.txt (~40 lines)
* All 3 AEs: event ID, description, CTCAE grade, onset day, resolution, causality, Physical AI assessment (all 5 categories), IRB reported, FDA reported
File 19: patient-journey/deliverables/tables/table_regulatory_sections.txt (~100 lines)
* Complete 84+ section listing by stage, organized by framework
File 20: patient-journey/deliverables/tables/table_module_activation.txt (~80 lines)
* 43 modules × 10 stages matrix showing which modules are active at each stage
File 21: patient-journey/deliverables/tables/table_digital_twin_predictions.txt (~50 lines)
* Twin predictions vs actual outcomes at every assessment point (volume, response, risk)
File 22: patient-journey/deliverables/tables/table_treatment_cycles.txt (~80 lines)
* Summary of all 35 immunotherapy cycles: cycle number, day, dose, labs, toxicities, imaging

SECTION E: FDA Cost-Savings Analysis
File 23: patient-journey/deliverables/fda_cost_savings/fda_savings_analysis.txt (~200-300 lines)
This file provides detailed, comprehensive estimates of how much Claude Code processing of the single prompt saves the FDA in money, time, and personnel at specific stages and for the whole process. Must use numbered lists and be exhaustively detailed.
Content structure:
Part 1: Executive Summary
* Total estimated savings per patient journey processed by Claude Code vs. manual traditional approach
* Headline numbers: cost savings ($), time savings (hours/days), personnel savings (FTEs)
Part 2: Stage-by-Stage Cost Savings (numbered list, all 10 stages)
1. Stage 1 — Pre-Screening & Referral Intake
    1. Traditional approach: Manual PHI review by 2 compliance officers × 8 hours = 16 person-hours at $85/hr = $1,360; FHIR mapping by health informaticist × 12 hours = $1,440; DICOM validation by medical physicist × 4 hours = $600. Total: $3,400, 3 business days, 3 staff.
    2. Claude Code approach: Automated PHI detection, de-identification pipeline, FHIR mapping, and DICOM validation executed in single prompt. Processing: ~15 minutes. Cost: ~$2 in API compute. Staff: 1 reviewer for 30-minute validation.
    3. Savings: $3,358 (98.8%), 2.9 business days, 2.6 FTEs per patient
    4. Key automation: PHI scanning across 18 HIPAA identifiers, ICD-10→SNOMED mapping, DICOM attribute validation
2. Stage 2 — Eligibility Screening & Enrollment (Similar detailed breakdown: traditional costs for eligibility committee review, consent form drafting by regulatory affairs, IRB submission preparation, randomization by biostatistician. Claude Code costs. Savings.)
3. Stage 3 — Digital Twin Construction (Traditional: computational biologist × 40 hours for tumor modeling, biostatistician × 20 hours for treatment simulation, V&V engineer × 16 hours. Claude Code: automated pipeline. Savings.)
4. Stage 4 — Robot Qualification (Traditional: robotics engineer × 24 hours USL scoring, safety engineer × 16 hours, cybersecurity analyst × 8 hours. Savings.)
5. Stage 5 — Surgery (NOTE: Claude Code automates documentation and monitoring setup, NOT the surgery itself) (Traditional: documentation by 2 staff × 8 hours post-procedure, telemetry review × 4 hours. Savings.)
6. Stage 6 — Recovery (Traditional: AE causality assessment by safety officer × 4 hours, GCP compliance check × 6 hours. Savings.)
7. Stage 7 — Immunotherapy (Traditional: cycle-by-cycle data management × 35 cycles × 2 hours = 70 person-hours, annual report compilation × 40 hours. Savings.)
8. Stage 8 — Federation (Traditional: data scientist × 80 hours for federated learning setup, privacy engineer × 40 hours for DP. Savings.)
9. Stage 9 — Surveillance (Traditional: data manager × 24 hours for follow-up data, biostatistician × 16 hours for analysis. Savings.)
10. Stage 10 — Closeout (Traditional: regulatory affairs × 80 hours for submission package, QA auditor × 40 hours for GCP audit. Savings.)
Part 3: Aggregate Savings Analysis (numbered list)
1. Total traditional cost per patient journey: estimated $XX,XXX (sum of all stages)
2. Total Claude Code cost per patient journey: estimated $XX (API compute + reviewer time)
3. Net savings per patient: $XX,XXX (XX% reduction)
4. Time savings: XX business days → XX hours (XX% reduction)
5. Personnel savings: XX FTEs → X FTE (XX% reduction)
6. Scale impact: For a 500-patient trial across 20 sites: $X.XM saved, X,XXX person-days saved
7. FDA review time impact: Standardized, machine-readable outputs reduce CDER review from ~XX days to ~X days per patient dataset
8. Quality improvement: Automated cross-validation eliminates ~XX% of human transcription errors
9. Regulatory consistency: 100% of 84+ sections verified programmatically vs. ~XX% manual spot-check
10. Audit readiness: 21 CFR Part 11 compliant audit trail generated automatically vs. manual log maintenance
Part 4: Strategic FDA Impact (numbered list)
1. New Drug Application (NDA) acceleration: standardized data format reduces FDA statistical review time
2. Pre-Approval Inspection (PAI) readiness: complete audit trail available instantly
3. Post-Market Requirements (PMR): surveillance data structure already in place
4. Advisory Committee preparation: visualization package ready for committee review
5. International harmonization: ICH E6(R3) compliance pre-verified, reducing multi-jurisdiction review
File 24: patient-journey/deliverables/fda_cost_savings/fda_savings_methodology.txt (~80-100 lines)
* Sources for cost estimates (BLS labor statistics, FDA MDUFA/PDUFA fee schedules, industry surveys)
* Assumptions and limitations
* Comparison methodology (traditional waterfall vs. automated pipeline)
* Confidence intervals on estimates

SECTION F: Field Observer Guide & Pharmaceutical Industry Briefing
File 25: patient-journey/deliverables/guidance/field_observer_guide.txt (~150-200 lines) Clear instructions for anyone observing the project in the field. Must explain:
1. What is this project? — A complete single-patient journey through a Physical AI oncology clinical trial, from referral to closeout, implemented as an automated software pipeline
2. What is the patient's journey? — Narrative walkthrough of PAT-2026-0042's experience in plain language:
    * Day −30: Referred by community oncologist with Stage IIIB NSCLC
    * Day −14: Records de-identified, data harmonized
    * Day 0: Deemed eligible, informed consent with Physical AI appendix, randomized to Arm A
    * Day 7: Digital twin built and validated
    * Day 14: Robots qualified, robotic-assisted surgery performed
    * Day 28: Recovered, pathology confirmed, immunotherapy begins
    * Month 24: 35 cycles completed, complete response
    * Month 36: Surveillance complete, event-free, trial closeout
3. What do the stages mean? — Plain-language explanation of each of the 10 stages and why they exist
4. What are the text diagrams? — How to read each of the 3 perspective types (Timeline, Regulatory, Clinical)
5. What are the Plotly charts? — How to generate them (python chart_XX_name.py), what each visualizes
6. What are the tables? — What data each table contains and how to interpret it
7. What is the regulatory framework? — Plain-language summary of the 3 regulatory adaptations and why Physical AI needs special regulation
8. Timeline visualization: A simplified ASCII timeline of the entire journey with day markers
File 26: patient-journey/deliverables/guidance/patient_journey_walkthrough.txt (~200-250 lines) A detailed, start-to-finish narrative of the patient's journey written as a continuous story, stage by stage, with:
* Clinical context for each decision
* What the software automates vs. what humans do
* Regulatory checkpoints and why they matter
* How Physical AI systems (robots, digital twins, AI agents) interact at each stage
* The patient's clinical outcome at each milestone
File 27: patient-journey/deliverables/guidance/repository_output_glossary.txt (~100-150 lines) A glossary explaining every file and directory produced by the pipeline:
* patient-journey/patient_state.py — "Central data model defining all enumerations and data structures..."
* patient-journey/stage_01_prescreening.py — "Orchestrator for Day −30 to −14, handling..."
* (Every file listed with 2-3 sentence explanation)
* patient-journey/diagrams/stage_XX/ — "Contains 3 cumulative progress diagrams for Stage XX..."
* patient-journey/deliverables/charts/ — "10 Plotly visualization scripts generating clinical trial charts..."
File 28: patient-journey/deliverables/guidance/pharmaceutical_industry_briefing.txt (~200-300 lines) A briefing document for pharmaceutical industry stakeholders based on what experts would expect for this project type:
1. Executive Summary — What was built, why it matters for the industry
2. Deliverable Package Contents — Inventory of everything produced (code, tests, diagrams, charts, tables, analysis)
3. Regulatory Readiness Assessment — How this pipeline accelerates IND filing, NDA submission, and post-market compliance
4. Technology Demonstration — What Physical AI capabilities are showcased (robotic surgery, digital twins, federated learning, agentic AI)
5. Cost-Benefit Analysis Summary — Key numbers from the FDA savings analysis
6. Integration Pathway — How pharmaceutical companies can adopt this framework:
    * Phase 1: Evaluate against existing clinical trial infrastructure
    * Phase 2: Pilot with single-site, single-patient validation
    * Phase 3: Multi-site deployment with federated learning
    * Phase 4: Full regulatory submission with automated packages
7. Expert Expectations — What clinical trial experts, FDA reviewers, and robotics engineers would evaluate:
    * Clinical validity of the patient data model
    * Regulatory traceability completeness
    * Software quality (test coverage, linting, documentation)
    * Visualization clarity for advisory committees
    * Reproducibility of the automated pipeline
8. Recommended Next Steps — Concrete actions for pharma sponsors considering Physical AI trials

SECTION G: Master Generation Script
File 29: patient-journey/deliverables/generate_all_deliverables.py (~200-250 lines) A single master script that:
1. Imports all 10 chart modules and calls create_chart() on each
2. Exports HTML files to patient-journey/deliverables/charts/output/
3. Attempts PNG export (graceful skip if kaleido not installed)
4. Prints a summary of all generated deliverables
5. Validates that all 30 stage diagram files exist
6. Validates that all 6 table files exist
7. Validates that all 4 guidance files exist
8. Validates that both FDA savings files exist
9. Prints the complete deliverable inventory

SECTION H: Tests
File 30: tests/test_patient_journey/test_deliverables.py (~300-350 lines) Comprehensive tests for all Commit 12 deliverables:
Tests (at least 20):
* Diagram tests:
    * test_three_standard_perspectives_exist — perspective_a, b, c in deliverables/diagrams/
    * test_three_additional_diagrams_exist — comprehensive_journey_map, regulatory_deep_dive, clinical_decision_flowchart
    * test_comprehensive_journey_map_covers_all_stages — mentions all 10 stages
    * test_regulatory_deep_dive_covers_three_frameworks — mentions 21 CFR 312, 21 CFR 50, ICH E6(R3)
    * test_clinical_flowchart_has_decision_points — contains YES/NO branches
* Chart tests:
    * test_all_10_chart_files_exist — chart_01 through chart_10 present
    * test_charts_have_create_chart_function — each imports plotly and defines create_chart()
    * test_chart_01_tumor_volume_data — correct volume trajectory
    * test_chart_05_usl_radar_scores — da Vinci 7.9, Franka 7.2
    * test_chart_10_kaplan_meier_hazard_ratio — HR 0.62
* Table tests:
    * test_all_6_table_files_exist — all tables present
    * test_stage_summary_table_10_rows — 10 stages listed
    * test_adverse_event_table_3_events — 3 AEs
    * test_regulatory_table_84_plus_sections — 84+ sections listed
* FDA savings tests:
    * test_fda_savings_analysis_exists — file present with content
    * test_fda_savings_has_10_stage_breakdowns — all 10 stages analyzed
    * test_fda_savings_has_aggregate_analysis — total savings computed
    * test_fda_savings_methodology_exists — methodology documented
* Guidance tests:
    * test_field_observer_guide_exists — guide present
    * test_patient_journey_walkthrough_covers_all_stages — all 10 stages narrated
    * test_pharmaceutical_briefing_has_all_sections — 8 sections present
Commit message:
Add Commit 12: Final deliverable package with visualizations, FDA
cost-savings analysis, and pharmaceutical industry guidance

Create comprehensive deliverable package including: 3 standard perspective
diagrams + 3 additional comprehensive/in-depth text diagrams, 10 colored
Plotly clinical trial charts (tumor trajectory, Gantt timeline, AE
waterfall, recurrence risk, USL radar, regulatory heatmap, module
sunburst, federation convergence, safety dashboard, KM curve), 6 text
tables, detailed FDA cost-savings analysis with per-stage and aggregate
estimates, field observer guide, patient journey walkthrough,
repository glossary, and pharmaceutical industry briefing. Includes
all Commit 11 verification files. 20 tests.

EXECUTION INSTRUCTIONS
1. Work on your designated branch. Create it if it doesn't exist.
2. Execute commits 1 through 12 sequentially. Each commit must be completed, committed, and pushed before moving to the next.
3. Do NOT overwrite files from prior commits. Each commit creates only NEW files. The only exception is Commit 11, which may fix lint/test issues in any file and updates CHANGELOG.md and ruff.toml.
4. Print a status update after each commit confirming: commit number, files created, test count, push status.
5. Do not stop or ask for input. Run fully autonomously through all 12 commits.
6. If a push fails due to network error, retry up to 4 times with exponential backoff (2s, 4s, 8s, 16s).
7. Target quality: Every file should be substantial (300-500 lines for orchestrators, 200-350 lines for test files, 40-80 lines for diagram files, 150-300 lines for deliverable files). Each method should have full docstrings, logging, error handling, and inline comments citing the governing Physical AI regulatory sections from the .tex files.
8. Use importlib.util.spec_from_file_location() in all test files to load modules from hyphenated directories, following the pattern in tests/conftest.py.
9. Commit 12 must contain ALL Commit 11 files (cross-stage consistency tests, CHANGELOG, ruff.toml updates) PLUS all new Commit 12 deliverables. The deliverables directory should be self-contained and easy to navigate from start to finish.

COMPLETE FILE MANIFEST (60+ files across 12 commits)
Commit	New Files	Lines (target)
1	__init__.py, patient_state.py, stage_01_prescreening.py, 3 diagram files, tests/__init__.py, test_stage_01	~1,350
2	stage_02_enrollment.py, 3 diagram files, test_stage_02	~825
3	stage_03_digital_twin.py, 3 diagram files, test_stage_03	~975
4	stage_04_robot_qualification.py, 3 diagram files, test_stage_04	~925
5	stage_05_surgery.py, 3 diagram files, test_stage_05	~1,075
6	stage_06_recovery.py, 3 diagram files, test_stage_06	~750
7	stage_07_immunotherapy.py, 3 diagram files, test_stage_07	~1,025
8	stage_08_federation.py, 3 diagram files, test_stage_08	~825
9	stage_09_surveillance.py, 3 diagram files, test_stage_09	~750
10	stage_10_closeout.py, master_journey.py, 3 diagram files, test_stage_10, test_master_journey	~1,600
11	test_cross_stage_consistency.py + fixes + CHANGELOG + ruff.toml	~600
12	6 diagrams, 10 charts, 6 tables, 2 FDA files, 4 guidance files, generate_all_deliverables.py, test_deliverables.py	~4,500
Total	60+ new files	~15,200 lines
REGULATORY COVERAGE SUMMARY
Regulatory Source	Sections Cited	Key Physical AI Sections
21 CFR Part 312	30+ sections	Subpart J (§ 312.400–405): Classification, Validation, Cybersecurity, Human Oversight, Lifecycle
21 CFR Part 50	15+ sections	New Subpart C (§ 50.30–34): Safety Matrix, IRB Review, Ongoing Consent, Data Protection, Classification
ICH E6(R3)	20+ subsections	§ 1.2 System Classification (7 types), § 1.4 Simulation/DT, § 1.5 USL, § 2.8 Consent (6 elements), § 2.10 Safety (5 AE categories), § 2.12 Oversight (5 review items)
TOTAL SYSTEM ENGAGEMENT FOR PAT-2026-0042
Metric	Value
Repository modules activated	43 of 51 (84%)
Regulatory sections governing journey	84+ (across 3 frameworks)
Total automated events	~2,400
Audit trail entries (21 CFR Part 11)	~8,500
Digital twin updates	~150
Safety monitoring data points	~10.8 million (1 kHz × 3 hr surgery)
Federated learning rounds	~70 (weekly × 24 months)
Treatment cycles	35 (pembrolizumab q3w × 2 years)
Human escalation events	3 (thyroid alert, rash assessment, EOT review)
Autonomous operation rate	97%
Patient timeline	Day −30 to Month 36+ (~1,126 days)
Plotly visualizations	10 colored clinical trial charts
Text diagrams	36 (30 stage + 6 deliverable)
Text tables	6
Guidance documents	4
FDA cost-savings documents	2
Total tests	185+
